<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Neuroblastoma - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Neuroblastoma" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Neuroblastoma&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Neuroblastoma&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Neuroblastoma" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Neuroblastoma" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Neuroblastoma","wgTitle":"Neuroblastoma","wgCurRevisionId":669877984,"wgRevisionId":669877984,"wgArticleId":1624266,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","All articles with dead external links","Articles with dead external links from April 2012","Articles with contributors link","Articles with DMOZ links","Articles that use a Medicine navs subtemplate","Good articles","Endocrine neoplasia","Small blue round cell tumor","Brain tumor","Dermal and subcutaneous growths","Rare cancers"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Neuroblastoma","wgRelevantArticleId":1624266,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Neuroepithelioma","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/e/e4/Neuroblastoma_rosettes.jpg/100px-Neuroblastoma_rosettes.jpg","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Neuroblastoma","wgWikibaseItemId":"Q938205"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Neuroblastoma skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
<div id="mw-indicator-good-star" class="mw-indicator"><a href="/wiki/Wikipedia:Good_articles" title="This is a good article. Click here for more information."><img alt="This is a good article. Click here for more information." src="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/19px-Symbol_support_vote.svg.png" width="19" height="20" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/29px-Symbol_support_vote.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/39px-Symbol_support_vote.svg.png 2x" data-file-width="180" data-file-height="185" /></a></div>
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Neuroblastoma</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Neuroepithelioma&amp;redirect=no" title="Neuroepithelioma">Neuroepithelioma</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Neuroblastoma, NOS</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Neuroblastoma_rosettes.jpg" class="image"><img alt="Neuroblastoma rosettes.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e4/Neuroblastoma_rosettes.jpg/230px-Neuroblastoma_rosettes.jpg" width="230" height="153" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e4/Neuroblastoma_rosettes.jpg/345px-Neuroblastoma_rosettes.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e4/Neuroblastoma_rosettes.jpg/460px-Neuroblastoma_rosettes.jpg 2x" data-file-width="1350" data-file-height="900" /></a>
<div>Microscopic view of a typical neuroblastoma with rosette formation</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Oncology" title="Oncology">Oncology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C74.9">C74.9</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=194.0">194.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a></th>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://www.progenetix.net/progenetix/I95003/">9500/3</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/256700">256700</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb8935.htm">8935</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/001408.htm">001408</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic2836.htm">med/2836</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/ped/topic1570.htm#">ped/1570</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/National_Cancer_Institute" title="National Cancer Institute">NCI</a></th>
<td><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/types/neuroblastoma">Neuroblastoma</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D009447">D009447</a></td>
</tr>
</table>
<p><b>Neuroblastoma</b> (<b>NB</b>) is the most common extracranial solid <a href="/wiki/Cancer" title="Cancer">cancer</a> in childhood and the most common cancer in infancy, with an incidence of about six hundred fifty cases per year in the U.S.,<sup id="cite_ref-titleeMedicine_-_Neuroblastoma_:_Article_by_Norman_J_Lacayo.2C_MD_1-0" class="reference"><a href="#cite_note-titleeMedicine_-_Neuroblastoma_:_Article_by_Norman_J_Lacayo.2C_MD-1"><span>[</span>1<span>]</span></a></sup> and a hundred cases per year in the UK.<sup id="cite_ref-2" class="reference"><a href="#cite_note-2"><span>[</span>2<span>]</span></a></sup> Nearly half of neuroblastoma cases occur in children younger than two years.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup> It is a <a href="/wiki/Neuroendocrine_tumor" title="Neuroendocrine tumor">neuroendocrine tumor</a>, arising from any <a href="/wiki/Neural_crest" title="Neural crest">neural crest</a> element of the <a href="/wiki/Sympathetic_nervous_system" title="Sympathetic nervous system">sympathetic nervous system</a> (SNS). It most frequently originates in one of the <a href="/wiki/Adrenal_gland" title="Adrenal gland">adrenal glands</a>, but can also develop in nerve tissues in the <a href="/wiki/Neck" title="Neck">neck</a>, <a href="/wiki/Chest" title="Chest" class="mw-redirect">chest</a>, <a href="/wiki/Abdomen" title="Abdomen">abdomen</a>, or <a href="/wiki/Pelvis" title="Pelvis">pelvis</a>.</p>
<p>Neuroblastoma is one of the few human malignancies known to demonstrate spontaneous regression from an undifferentiated state to a completely <a href="/wiki/Benign" title="Benign" class="mw-redirect">benign</a> cellular appearance.<sup id="cite_ref-pmid19383347_4-0" class="reference"><a href="#cite_note-pmid19383347-4"><span>[</span>4<span>]</span></a></sup> It is a disease exhibiting extreme <a href="/wiki/Heterogeneity" title="Heterogeneity" class="mw-redirect">heterogeneity</a>, and is stratified into three risk categories: low, intermediate, and high risk. Low-risk disease is most common in infants and good outcomes are common with observation only or surgery, whereas high-risk disease is difficult to treat successfully even with the most intensive multi-modal therapies available.<sup id="cite_ref-urlScienceDirect_-_The_Lancet_:_Neuroblastoma_5-0" class="reference"><a href="#cite_note-urlScienceDirect_-_The_Lancet_:_Neuroblastoma-5"><span>[</span>5<span>]</span></a></sup></p>
<p><a href="/wiki/Esthesioneuroblastoma" title="Esthesioneuroblastoma">Esthesioneuroblastoma</a>, also known as olfactory neuroblastoma, is believed to arise from the <a href="/wiki/Olfactory_epithelium" title="Olfactory epithelium">olfactory epithelium</a> and its classification remains controversial. However, since it is not a sympathetic nervous system malignancy, esthesioneuroblastoma is a distinct clinical entity and is not to be confused with neuroblastoma.<sup id="cite_ref-titleeMedicine_-_Esthesioneuroblastoma_:_Article_by_Pavel_Dulguerov.2C_MD_6-0" class="reference"><a href="#cite_note-titleeMedicine_-_Esthesioneuroblastoma_:_Article_by_Pavel_Dulguerov.2C_MD-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Cause"><span class="tocnumber">2</span> <span class="toctext">Cause</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-4"><a href="#Biochemistry"><span class="tocnumber">3.1</span> <span class="toctext">Biochemistry</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Imaging"><span class="tocnumber">3.2</span> <span class="toctext">Imaging</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Histology"><span class="tocnumber">3.3</span> <span class="toctext">Histology</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Staging"><span class="tocnumber">3.4</span> <span class="toctext">Staging</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#Screening"><span class="tocnumber">4</span> <span class="toctext">Screening</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#Treatment"><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-1 tocsection-10"><a href="#Prognosis"><span class="tocnumber">6</span> <span class="toctext">Prognosis</span></a>
<ul>
<li class="toclevel-2 tocsection-11"><a href="#Cytogenetic_profiles"><span class="tocnumber">6.1</span> <span class="toctext">Cytogenetic profiles</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Epidemiology"><span class="tocnumber">7</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#History"><span class="tocnumber">8</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#Society_and_culture"><span class="tocnumber">9</span> <span class="toctext">Society and culture</span></a>
<ul>
<li class="toclevel-2 tocsection-15"><a href="#Legislative_efforts"><span class="tocnumber">9.1</span> <span class="toctext">Legislative efforts</span></a></li>
<li class="toclevel-2 tocsection-16"><a href="#Fundraising"><span class="tocnumber">9.2</span> <span class="toctext">Fundraising</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-17"><a href="#Research"><span class="tocnumber">10</span> <span class="toctext">Research</span></a>
<ul>
<li class="toclevel-2 tocsection-18"><a href="#Treatments"><span class="tocnumber">10.1</span> <span class="toctext">Treatments</span></a></li>
<li class="toclevel-2 tocsection-19"><a href="#Refractory_and_relapsed_neuroblastoma"><span class="tocnumber">10.2</span> <span class="toctext">Refractory and relapsed neuroblastoma</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-20"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-21"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The first <a href="/wiki/Symptom" title="Symptom">symptoms</a> of neuroblastoma are often vague making diagnosis difficult. <a href="/wiki/Fatigue_(medical)" title="Fatigue (medical)">Fatigue</a>, <a href="/wiki/Loss_of_appetite" title="Loss of appetite" class="mw-redirect">loss of appetite</a>, <a href="/wiki/Fever" title="Fever">fever</a>, and joint pain are common. Symptoms depend on primary tumor locations and metastases if present:<sup id="cite_ref-titleNeuroblastoma_in_children_:_Cancerbackup_8-0" class="reference"><a href="#cite_note-titleNeuroblastoma_in_children_:_Cancerbackup-8"><span>[</span>8<span>]</span></a></sup></p>
<ul>
<li>In the <a href="/wiki/Abdomen" title="Abdomen">abdomen</a>, a tumor may cause a <a href="/wiki/Swollen_belly" title="Swollen belly" class="mw-redirect">swollen belly</a> and <a href="/wiki/Constipation" title="Constipation">constipation</a>.</li>
<li>A tumor in the <a href="/wiki/Chest" title="Chest" class="mw-redirect">chest</a> may cause <a href="/wiki/Breathing_problems" title="Breathing problems" class="mw-redirect">breathing problems</a>.</li>
<li>A tumor pressing on the <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a> may cause <a href="/wiki/Weakness" title="Weakness">weakness</a> and thus an inability to stand, crawl, or walk.</li>
<li>Bone lesions in the legs and hips may cause pain and limping.</li>
<li>A tumor in the bones around the eyes or <a href="/wiki/Orbit_(anatomy)" title="Orbit (anatomy)">orbits</a> may cause distinct bruising and swelling.</li>
<li>Infiltration of the bone marrow may cause <a href="/wiki/Pallor" title="Pallor">pallor</a> from <a href="/wiki/Anemia" title="Anemia">anemia</a>.</li>
</ul>
<p>Neuroblastoma often spreads to other parts of the body before any symptoms are apparent and 50 to 60% of all neuroblastoma cases present with <a href="/wiki/Metastasis" title="Metastasis">metastases</a>.<sup id="cite_ref-titleNeuroblastoma:_Pediatric_Cancers:_Merck_Manual_Professional_9-0" class="reference"><a href="#cite_note-titleNeuroblastoma:_Pediatric_Cancers:_Merck_Manual_Professional-9"><span>[</span>9<span>]</span></a></sup></p>
<p>The most common location for neuroblastoma to originate (i.e., the primary tumor) is on the adrenal glands. This occurs in 40% of localized tumors and in 60% of cases of widespread disease. Neuroblastoma can also develop anywhere along the sympathetic nervous system chain from the neck to the pelvis. Frequencies in different locations include: neck (1%), chest (19%), abdomen (30% non-adrenal), or pelvis (1%). In rare cases, no primary tumor can be discerned.<sup id="cite_ref-pmid17943963_10-0" class="reference"><a href="#cite_note-pmid17943963-10"><span>[</span>10<span>]</span></a></sup></p>
<p>Rare but characteristic presentations include transverse <a href="/wiki/Myelopathy" title="Myelopathy">myelopathy</a> (tumor spinal cord compression, 5% of cases), treatment-resistant diarrhea (tumor <a href="/wiki/Vasoactive_intestinal_peptide" title="Vasoactive intestinal peptide">vasoactive intestinal peptide</a> secretion, 4% of cases), <a href="/wiki/Horner%27s_syndrome" title="Horner's syndrome">Horner's syndrome</a> (cervical tumor, 2.4% of cases), <a href="/wiki/Opsoclonus_myoclonus_syndrome" title="Opsoclonus myoclonus syndrome">opsoclonus myoclonus syndrome</a><sup id="cite_ref-pmid19430769_11-0" class="reference"><a href="#cite_note-pmid19430769-11"><span>[</span>11<span>]</span></a></sup> and <a href="/wiki/Ataxia" title="Ataxia">ataxia</a> (suspected <a href="/wiki/Paraneoplastic" title="Paraneoplastic" class="mw-redirect">paraneoplastic</a> cause, 1.3% of cases), and <a href="/wiki/Hypertension" title="Hypertension">hypertension</a> (<a href="/wiki/Catecholamine" title="Catecholamine">catecholamine</a> secretion or renal artery compression, 1.3% of cases).<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Cause">Cause</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=2" title="Edit section: Cause">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The <a href="/wiki/Etiology" title="Etiology">etiology</a> of neuroblastoma is not well understood. The great majority of cases are sporadic and non-familial. About 1-2% of cases run in families and have been linked to specific gene mutations. Familial neuroblastoma in some cases is caused by rare germline mutations in the <a href="/wiki/Anaplastic_lymphoma_kinase" title="Anaplastic lymphoma kinase">anaplastic lymphoma kinase</a> (ALK) gene.<sup id="cite_ref-pmid18724359_13-0" class="reference"><a href="#cite_note-pmid18724359-13"><span>[</span>13<span>]</span></a></sup> Germline mutations in the <a href="/wiki/PHOX2A" title="PHOX2A">PHOX2A</a> or <a href="/wiki/KIF1B" title="KIF1B">KIF1B</a> gene have been implicated in familial neuroblastoma as well. Neuroblastoma is also a feature of <a href="/wiki/Neurofibromatosis_type_1" title="Neurofibromatosis type 1" class="mw-redirect">neurofibromatosis type 1</a> and the <a href="/wiki/Beckwith-Wiedemann_syndrome" title="Beckwith-Wiedemann syndrome" class="mw-redirect">Beckwith-Wiedemann syndrome</a>.</p>
<p><a href="/wiki/MYCN" title="MYCN" class="mw-redirect">MYCN</a> <a href="/wiki/Oncogene" title="Oncogene">oncogene</a> amplification within the tumor is a common finding in neuroblastoma. The degree of amplification shows a bimodal distribution: either 3- to 10-fold, or 100- to 300-fold. The presence of this mutation is highly correlated to advanced stages of disease.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup></p>
<p>Duplicated segments of the <a href="/wiki/LMO1" title="LMO1">LMO1</a> gene within neuroblastoma tumor cells have been shown to increase the risk of developing an aggressive form of the cancer.<sup id="cite_ref-lmo1_contributor_15-0" class="reference"><a href="#cite_note-lmo1_contributor-15"><span>[</span>15<span>]</span></a></sup></p>
<p>Neuroblastoma has been linked to <a href="/wiki/Copy-number_variation" title="Copy-number variation">copy-number variation</a> within the <a href="/wiki/NBPF10" title="NBPF10">NBPF10</a> gene, which results in the <a href="/wiki/1q21.1_deletion_syndrome" title="1q21.1 deletion syndrome">1q21.1 deletion syndrome</a> or <a href="/wiki/1q21.1_duplication_syndrome" title="1q21.1 duplication syndrome">1q21.1 duplication syndrome</a>.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup></p>
<p>Several risk factors have been proposed and are the subject of ongoing research. Due to characteristic early onset many studies have focused on parental factors around <a href="/wiki/Fertilisation" title="Fertilisation">conception</a> and during <a href="/wiki/Gestation" title="Gestation">gestation</a>. Factors investigated have included occupation (i.e. exposure to chemicals in specific industries), smoking, alcohol consumption, use of medicinal drugs during pregnancy and birth factors; however, results have been inconclusive.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup></p>
<p>Other studies have examined possible links with <a href="/wiki/Atopy" title="Atopy">atopy</a> and exposure to <a href="/wiki/Infection" title="Infection">infection</a> early in life,<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> use of hormones and fertility drugs,<sup id="cite_ref-Olshan_et_al._1999_19-0" class="reference"><a href="#cite_note-Olshan_et_al._1999-19"><span>[</span>19<span>]</span></a></sup> and maternal use of hair dye.<sup id="cite_ref-McCall_EE.2C.27.27et_al..27.27_2005_20-0" class="reference"><a href="#cite_note-McCall_EE.2C.27.27et_al..27.27_2005-20"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-pmid19159399_21-0" class="reference"><a href="#cite_note-pmid19159399-21"><span>[</span>21<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=3" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Neuroblastoma_mets.JPG" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/20/Neuroblastoma_mets.JPG/220px-Neuroblastoma_mets.JPG" width="220" height="252" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/2/20/Neuroblastoma_mets.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/2/20/Neuroblastoma_mets.JPG 2x" data-file-width="321" data-file-height="367" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Neuroblastoma_mets.JPG" class="internal" title="Enlarge"></a></div>
MRI showing orbital and skull vault metastatic NB in 2 year old</div>
</div>
</div>
<p>The diagnosis is usually confirmed by a <a href="/wiki/Anatomical_pathology" title="Anatomical pathology">surgical pathologist</a>, taking into account the clinical presentation, microscopic findings, and other laboratory tests.</p>
<h3><span class="mw-headline" id="Biochemistry">Biochemistry</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=4" title="Edit section: Biochemistry">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In about 90% of cases of neuroblastoma, elevated levels of <a href="/wiki/Catecholamines" title="Catecholamines" class="mw-redirect">catecholamines</a> or their metabolites are found in the urine or blood. Catecholamines and their metabolites include <a href="/wiki/Dopamine" title="Dopamine">dopamine</a>, <a href="/wiki/Homovanillic_acid" title="Homovanillic acid">homovanillic acid</a> (HVA), and/or <a href="/wiki/Vanillylmandelic_acid" title="Vanillylmandelic acid">vanillylmandelic acid</a> (VMA).<sup id="cite_ref-pmid16732582_22-0" class="reference"><a href="#cite_note-pmid16732582-22"><span>[</span>22<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Imaging">Imaging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=5" title="Edit section: Imaging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Another way to detect neuroblastoma is the <a href="/wiki/MIBG" title="MIBG" class="mw-redirect">mIBG</a> scan (meta-iodobenzylguanidine), which is taken up by 90 to 95% of all neuroblastomas, often termed "mIBG-avid."<sup id="cite_ref-pmid17544628_23-0" class="reference"><a href="#cite_note-pmid17544628-23"><span>[</span>23<span>]</span></a></sup> The mechanism is that mIBG is taken up by sympathetic neurons, and is a functioning analog of the neurotransmitter <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a>. When it is radio-ionated with <a href="/wiki/I-131" title="I-131" class="mw-redirect">I-131</a> or I-123 (radioactive iodine <a href="/wiki/Isotopes" title="Isotopes" class="mw-redirect">isotopes</a>), it is a very good <a href="/wiki/Radiopharmaceutical" title="Radiopharmaceutical" class="mw-redirect">radiopharmaceutical</a> for diagnosis and monitoring of response to treatment for this disease. With a <a href="/wiki/Half-life" title="Half-life">half-life</a> of 13 hours, I-123 is the preferred isotope for imaging sensitivity and quality. I-131 has a half-life of 8 days and at higher doses is an effective therapy as targeted radiation against relapsed and refractory neuroblastoma.<sup id="cite_ref-pmid15653652_24-0" class="reference"><a href="#cite_note-pmid15653652-24"><span>[</span>24<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Histology">Histology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=6" title="Edit section: Histology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Neuroblastoma.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Neuroblastoma.jpg/220px-Neuroblastoma.jpg" width="220" height="147" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Neuroblastoma.jpg/330px-Neuroblastoma.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0d/Neuroblastoma.jpg/440px-Neuroblastoma.jpg 2x" data-file-width="2700" data-file-height="1800" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Neuroblastoma.jpg" class="internal" title="Enlarge"></a></div>
microscopic view of stroma-rich ganglioneuroblastoma</div>
</div>
</div>
<p>On microscopy, the tumor cells are typically described as small, round and blue, and <a href="/wiki/Rosette_(design)" title="Rosette (design)">rosette</a> patterns (<a href="/wiki/James_Homer_Wright" title="James Homer Wright">Homer-Wright</a> rosettes) may be seen. Homer-Wright rosettes are tumor cells around neuropil, not to be confused with pseudorosettes which are tumor cells around a blood vessel.<sup id="cite_ref-pmid11844067_25-0" class="reference"><a href="#cite_note-pmid11844067-25"><span>[</span>25<span>]</span></a></sup> They are also distinct from the pseudorosettes of an ependymoma which consist of tumor cells with glial fibrillary acidic protein (GFAP)–positive processes tapering off toward a blood vessel (thus a combination of the two).<sup id="cite_ref-26" class="reference"><a href="#cite_note-26"><span>[</span>26<span>]</span></a></sup> A variety of immunohistochemical stains are used by pathologists to distinguish neuroblastomas from histological mimics, such as <a href="/wiki/Rhabdomyosarcoma" title="Rhabdomyosarcoma">rhabdomyosarcoma</a>, <a href="/wiki/Ewing%27s_sarcoma" title="Ewing's sarcoma">Ewing's sarcoma</a>, <a href="/wiki/Lymphoma" title="Lymphoma">lymphoma</a> and <a href="/wiki/Wilms%27_tumor" title="Wilms' tumor">Wilms' tumor</a>.</p>
<p>Neuroblastoma is one of the peripheral neuroblastic <a href="/wiki/Tumors" title="Tumors" class="mw-redirect">tumors</a> (pNTs) that have similar origins and show a wide pattern of differentiation ranging from <a href="/wiki/Benign" title="Benign" class="mw-redirect">benign</a> <a href="/wiki/Ganglioneuroma" title="Ganglioneuroma">ganglioneuroma</a> to <a href="/wiki/Stroma_(animal_tissue)" title="Stroma (animal tissue)">stroma</a>-rich <a href="/wiki/Ganglioneuroblastoma" title="Ganglioneuroblastoma">ganglioneuroblastoma</a> with neuroblastic cells intermixed or in nodules, to highly malignant neuroblastoma. This distinction in the pre-treatment tumor pathology is an important prognostic factor, along with age and <a href="/wiki/Mitosis" title="Mitosis">mitosis</a>-<a href="/wiki/Karyorrhexis" title="Karyorrhexis">karyorrhexis</a> index (MKI). This pathology classification system describes "favorable" and "unfavorable" tumors by the International Neuroblastoma Pathology Committee (INPC, also called Shimada system) which was established in 1999 and revised in 2003.<sup id="cite_ref-pmid14601099_27-0" class="reference"><a href="#cite_note-pmid14601099-27"><span>[</span>27<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Staging">Staging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=7" title="Edit section: Staging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The "International Neuroblastoma Staging System" (INSS) established in 1986 and revised in 1988 stratifies neuroblastoma according to its anatomical presence at diagnosis:<sup id="cite_ref-titleNeuroblastoma_Treatment_-_National_Cancer_Institute_28-0" class="reference"><a href="#cite_note-titleNeuroblastoma_Treatment_-_National_Cancer_Institute-28"><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-pmid3199170_29-0" class="reference"><a href="#cite_note-pmid3199170-29"><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-pmid8336186_30-0" class="reference"><a href="#cite_note-pmid8336186-30"><span>[</span>30<span>]</span></a></sup></p>
<ul>
<li>Stage 1: Localized tumor confined to the area of origin.</li>
</ul>
<ul>
<li>Stage 2A: Unilateral tumor with incomplete gross resection; identifiable ipsilateral and contralateral lymph node negative for tumor.</li>
</ul>
<ul>
<li>Stage 2B: Unilateral tumor with complete or incomplete gross resection; with ipsilateral lymph node positive for tumor; identifiable contralateral lymph node negative for tumor.</li>
</ul>
<ul>
<li>Stage 3: Tumor infiltrating across midline with or without regional lymph node involvement; or unilateral tumor with contralateral lymph node involvement; or midline tumor with bilateral lymph node involvement.</li>
</ul>
<ul>
<li>Stage 4: Dissemination of tumor to distant lymph nodes, bone marrow, bone, liver, or other organs except as defined by Stage 4S.</li>
</ul>
<ul>
<li>Stage 4S: Age &lt;1 year old with localized primary tumor as defined in Stage 1 or 2, with dissemination limited to liver, skin, or bone marrow (less than 10 percent of nucleated bone marrow cells are tumors).</li>
</ul>
<p>Although international agreement on staging (INSS) has been used, the need for an international consensus on risk assignment has also been recognized in order to compare similar cohorts in results of studies. Beginning in 2005, representatives of the major pediatric oncology cooperative groups have met to review data for 8,800 neuroblastoma patients treated in Europe, Japan, USA, Canada, and Australia between 1990 and 2002. This task force has proposed the International Neuroblastoma Risk Group (INRG) classification system. Retrospective studies revealed the high survival rate of 12-18 month old age group, previously categorized as high-risk, and prompted the decision to reclassify 12-18 month old children without N-<i>myc</i> (also commonly referred to as <a href="/wiki/MYCN" title="MYCN" class="mw-redirect">MYCN</a>) amplification to intermediate risk category.<sup id="cite_ref-pmid16116154_31-0" class="reference"><a href="#cite_note-pmid16116154-31"><span>[</span>31<span>]</span></a></sup></p>
<p>The new INRG risk assignment will classify neuroblastoma at diagnosis based on a new International Neuroblastoma Risk Group Staging System (INRGSS):</p>
<ul>
<li>Stage L1: Localized disease without image-defined risk factors.</li>
</ul>
<ul>
<li>Stage L2: Localized disease with image-defined risk factors.</li>
</ul>
<ul>
<li>Stage M: Metastatic disease.</li>
</ul>
<ul>
<li>Stage MS: Metastatic disease "special" where MS is equivalent to stage 4S.</li>
</ul>
<p>The new risk stratification will be based on the new INRGSS staging system, age (dichotomized at 18 months), tumor grade, <a href="/wiki/N-myc" title="N-myc" class="mw-redirect">N-myc</a> amplification, unbalanced 11q aberration, and <a href="/wiki/Ploidy" title="Ploidy">ploidy</a> into four pre-treatment risk groups: very low, low, intermediate, and high risk.<sup id="cite_ref-pmid17586306_32-0" class="reference"><a href="#cite_note-pmid17586306-32"><span>[</span>32<span>]</span></a></sup><sup id="cite_ref-pmid_33-0" class="reference"><a href="#cite_note-pmid-33"><span>[</span>33<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Screening">Screening</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=8" title="Edit section: Screening">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Urine <a href="/wiki/Catecholamine" title="Catecholamine">catecholamine</a> level can be elevated in pre-clinical neuroblastoma. Screening asymptomatic infants at three weeks, six months, and one year has been performed in Japan, Canada, Austria and Germany since the 1980s.<sup id="cite_ref-pmid11932470_34-0" class="reference"><a href="#cite_note-pmid11932470-34"><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-pmid12880955_35-0" class="reference"><a href="#cite_note-pmid12880955-35"><span>[</span>35<span>]</span></a></sup> Japan began screening six-month-olds for neuroblastoma via analysis of the levels of <a href="/wiki/Homovanillic_acid" title="Homovanillic acid">homovanillic acid</a> and <a href="/wiki/Vanilmandelic_acid" title="Vanilmandelic acid" class="mw-redirect">vanilmandelic acid</a> in 1984. Screening was halted in 2004 after studies in Canada and Germany showed no reduction in deaths due to neuroblastoma, but rather caused an increase in diagnoses that would have disappeared without treatment, subjecting those infants to unnecessary surgery and chemotherapy.<sup id="cite_ref-pmid15128908_36-0" class="reference"><a href="#cite_note-pmid15128908-36"><span>[</span>36<span>]</span></a></sup><sup id="cite_ref-titleNeuroblastoma_Screening_-_National_Cancer_Institute_37-0" class="reference"><a href="#cite_note-titleNeuroblastoma_Screening_-_National_Cancer_Institute-37"><span>[</span>37<span>]</span></a></sup> <sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span>[</span>38<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=9" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>When the <a href="/wiki/Lesion" title="Lesion">lesion</a> is localized, it is generally curable. However, long-term survival for children with advanced disease older than 18 months of age is poor despite aggressive <a href="/wiki/Multimodal_therapy" title="Multimodal therapy">multimodal therapy</a> (intensive <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>, <a href="/wiki/Surgery" title="Surgery">surgery</a>, <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a>, <a href="/wiki/Stem_cell_transplant" title="Stem cell transplant" class="mw-redirect">stem cell transplant</a>, <a href="/wiki/Differentiation_(cellular)" title="Differentiation (cellular)" class="mw-redirect">differentiation</a> agent <a href="/wiki/Isotretinoin" title="Isotretinoin">isotretinoin</a> also called 13-<i>cis</i>-retinoic acid, and frequently <a href="/wiki/Immunotherapy" title="Immunotherapy">immunotherapy</a><sup id="cite_ref-pmid18081947_39-0" class="reference"><a href="#cite_note-pmid18081947-39"><span>[</span>39<span>]</span></a></sup> with anti-<a href="/wiki/GD2" title="GD2">GD2</a> <a href="/wiki/Monoclonal_antibody_therapy" title="Monoclonal antibody therapy">monoclonal antibody therapy</a>).</p>
<p>Biologic and genetic characteristics have been identified, which, when added to classic clinical staging, has allowed patient assignment to risk groups for planning treatment intensity.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40"><span>[</span>40<span>]</span></a></sup> These criteria include the age of the patient, extent of disease spread, microscopic appearance, and genetic features including DNA ploidy and <a href="/wiki/N-myc" title="N-myc" class="mw-redirect">N-myc</a> <a href="/wiki/Oncogene" title="Oncogene">oncogene</a> amplification (N-myc regulates <a href="/wiki/MicroRNA" title="MicroRNA">microRNAs</a><sup id="cite_ref-pmid17943719_41-0" class="reference"><a href="#cite_note-pmid17943719-41"><span>[</span>41<span>]</span></a></sup>), into low, intermediate, and high risk disease. A recent biology study (COG ANBL00B1) analyzed 2687 neuroblastoma patients and the spectrum of risk assignment was determined: 37% of neuroblastoma cases are low risk, 18% are intermediate risk, and 45% are high risk.<sup id="cite_ref-titleTranslating_Neuroblastoma_Genomics_to_the_Clinic_-_J._Maris_presentation_ASCO_2007_42-0" class="reference"><a href="#cite_note-titleTranslating_Neuroblastoma_Genomics_to_the_Clinic_-_J._Maris_presentation_ASCO_2007-42"><span>[</span>42<span>]</span></a></sup> (There is some evidence that the high- and low-risk types are caused by different mechanisms, and are not merely two different degrees of expression of the same mechanism.)<sup id="cite_ref-pmid17897457_43-0" class="reference"><a href="#cite_note-pmid17897457-43"><span>[</span>43<span>]</span></a></sup></p>
<p>The therapies for these different risk categories are very different.</p>
<ul>
<li>Low-risk disease can frequently be <a href="/wiki/Watchful_waiting" title="Watchful waiting">observed without any treatment at all</a> or cured with surgery alone.<sup id="cite_ref-titleNeuroblastoma_Treatment_-_National_Cancer_Institute_28-1" class="reference"><a href="#cite_note-titleNeuroblastoma_Treatment_-_National_Cancer_Institute-28"><span>[</span>28<span>]</span></a></sup></li>
</ul>
<ul>
<li>Intermediate-risk disease is treated with surgery and <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>.<sup id="cite_ref-pmid9988866_44-0" class="reference"><a href="#cite_note-pmid9988866-44"><span>[</span>44<span>]</span></a></sup></li>
</ul>
<ul>
<li>High-risk neuroblastoma is treated with intensive chemotherapy, <a href="/wiki/Surgery" title="Surgery">surgery</a>, <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a>, <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a> / <a href="/wiki/Hematopoietic_stem_cell_transplantation" title="Hematopoietic stem cell transplantation">hematopoietic stem cell transplantation</a>,<sup id="cite_ref-pmid18037943_45-0" class="reference"><a href="#cite_note-pmid18037943-45"><span>[</span>45<span>]</span></a></sup> biological-based therapy with 13-<i>cis</i>-retinoic acid (<a href="/wiki/Isotretinoin" title="Isotretinoin">isotretinoin</a> or Accutane)<sup id="cite_ref-pmid10519894_46-0" class="reference"><a href="#cite_note-pmid10519894-46"><span>[</span>46<span>]</span></a></sup> and antibody therapy usually administered with the <a href="/wiki/Cytokines" title="Cytokines" class="mw-redirect">cytokines</a> <a href="/wiki/GM-CSF" title="GM-CSF" class="mw-redirect">GM-CSF</a> and <a href="/wiki/Interleukin_2" title="Interleukin 2">IL-2</a>.<sup id="cite_ref-pmid20879881_47-0" class="reference"><a href="#cite_note-pmid20879881-47"><span>[</span>47<span>]</span></a></sup></li>
</ul>
<p>With current treatments, patients with low and intermediate risk disease have an excellent prognosis with cure rates above 90% for low risk and 70%-90% for intermediate risk. In contrast, therapy for high-risk neuroblastoma the past two decades resulted in cures only about 30% of the time.<sup id="cite_ref-titleNeuroblastoma_Treatment_-_National_Cancer_Institute_.282.29_48-0" class="reference"><a href="#cite_note-titleNeuroblastoma_Treatment_-_National_Cancer_Institute_.282.29-48"><span>[</span>48<span>]</span></a></sup> The addition of antibody therapy has raised survival rates for high-risk disease significantly. In March 2009 an early analysis of a Children's Oncology Group (COG) study with 226 high-risk patients showed that two years after stem cell transplant 66% of the group randomized to received ch14.18 antibody with <a href="/wiki/GM-CSF" title="GM-CSF" class="mw-redirect">GM-CSF</a> and <a href="/wiki/Interleukin_2" title="Interleukin 2">IL-2</a> were alive and disease-free compared to only 46% in the group that did not receive the antibody. The randomization was stopped so all patients enrolling on the trial will receive the antibody therapy.<sup id="cite_ref-urlA_phase_III_randomized_trial_of_the_chimeric_anti-GD2_antibody_ch14.18_with_GM-CSF_and_IL2_as_immunotherapy_following_dose_intensive_chemotherapy_for_high-risk_neuroblastoma:_Children.27s_Oncology_Group_.28COG.29_study_ANBL0032_49-0" class="reference"><a href="#cite_note-urlA_phase_III_randomized_trial_of_the_chimeric_anti-GD2_antibody_ch14.18_with_GM-CSF_and_IL2_as_immunotherapy_following_dose_intensive_chemotherapy_for_high-risk_neuroblastoma:_Children.27s_Oncology_Group_.28COG.29_study_ANBL0032-49"><span>[</span>49<span>]</span></a></sup></p>
<p>Chemotherapy agents used in combination have been found to be effective against neuroblastoma. Agents commonly used in induction and for stem cell transplant conditioning are platinum compounds (<a href="/wiki/Cisplatin" title="Cisplatin">cisplatin</a>, <a href="/wiki/Carboplatin" title="Carboplatin">carboplatin</a>), alkylating agents (<a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>, <a href="/wiki/Ifosfamide" title="Ifosfamide">ifosfamide</a>, <a href="/wiki/Melphalan" title="Melphalan">melphalan</a>), <a href="/wiki/Topoisomerase" title="Topoisomerase">topoisomerase</a> II inhibitor (<a href="/wiki/Etoposide" title="Etoposide">etoposide</a>), <a href="/wiki/Anthracycline" title="Anthracycline">anthracycline</a> antibiotics (<a href="/wiki/Doxorubicin" title="Doxorubicin">doxorubicin</a>) and vinca <a href="/wiki/Alkaloids" title="Alkaloids" class="mw-redirect">alkaloids</a> (<a href="/wiki/Vincristine" title="Vincristine">vincristine</a>). Some newer regimens include topoisomerase I inhibitors (<a href="/wiki/Topotecan" title="Topotecan">topotecan</a> and <a href="/wiki/Irinotecan" title="Irinotecan">irinotecan</a>) in induction which have been found to be effective against recurrent disease.</p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=10" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Between 20% and 50% of high-risk cases do not respond adequately to induction high-dose chemotherapy and are progressive or refractory.<sup id="cite_ref-urlReduction_From_Seven_to_Five_Cycles_of_Intensive_Induction_Chemotherapy_in_Children_With_High-Risk_Neuroblastoma_--_Kushner_et_al._22_.2824.29:_4888_--_Journal_of_Clinical_Oncology_50-0" class="reference"><a href="#cite_note-urlReduction_From_Seven_to_Five_Cycles_of_Intensive_Induction_Chemotherapy_in_Children_With_High-Risk_Neuroblastoma_--_Kushner_et_al._22_.2824.29:_4888_--_Journal_of_Clinical_Oncology-50"><span>[</span>50<span>]</span></a></sup><sup id="cite_ref-titleResponse_and_toxicity_to_a_dose-intensive_multi-agent_chemotherapy_induction_regimen_for_high_risk_neuroblastoma_.28HR-NB.29:_A_Childrens_Oncology_Group_.28COG_A3973.29_study._-_ASCO_51-0" class="reference"><a href="#cite_note-titleResponse_and_toxicity_to_a_dose-intensive_multi-agent_chemotherapy_induction_regimen_for_high_risk_neuroblastoma_.28HR-NB.29:_A_Childrens_Oncology_Group_.28COG_A3973.29_study._-_ASCO-51"><span>[</span>51<span>]</span></a></sup> Relapse after completion of frontline therapy is also common. Further treatment is available in phase I and phase II clinical trials that test new agents and combinations of agents against neuroblastoma, but the outcome remains very poor for relapsed high-risk disease.<sup id="cite_ref-pmid16395684_52-0" class="reference"><a href="#cite_note-pmid16395684-52"><span>[</span>52<span>]</span></a></sup></p>
<p>Most long-term survivors alive today had low or intermediate risk disease and milder courses of treatment compared to high-risk disease. The majority of survivors have long-term effects from the treatment. Survivors of intermediate and high-risk treatment often experience hearing loss. Growth reduction, thyroid function disorders, learning difficulties, and greater risk of secondary cancers affect survivors of high-risk disease.<sup id="cite_ref-pmid17974716_53-0" class="reference"><a href="#cite_note-pmid17974716-53"><span>[</span>53<span>]</span></a></sup><sup id="cite_ref-pmid17724446_54-0" class="reference"><a href="#cite_note-pmid17724446-54"><span>[</span>54<span>]</span></a></sup> An estimated two of three survivors of childhood cancer will ultimately develop at least one chronic and sometimes life-threatening health problem within 20 to 30 years after the cancer diagnosis.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55"><span>[</span>55<span>]</span></a></sup><sup id="cite_ref-56" class="reference"><a href="#cite_note-56"><span>[</span>56<span>]</span></a></sup><sup id="cite_ref-urlLong-term_Outcomes_in_Survivors_of_Neuroblastoma:_A_Report_From_the_Childhood_Cancer_Survivor_Study_--_Laverdi.C3.A8re_et_al..2C_10.1093.2Fjnci.2Fdjp230_--_JNCI_Journal_of_the_National_Cancer_Institute_57-0" class="reference"><a href="#cite_note-urlLong-term_Outcomes_in_Survivors_of_Neuroblastoma:_A_Report_From_the_Childhood_Cancer_Survivor_Study_--_Laverdi.C3.A8re_et_al..2C_10.1093.2Fjnci.2Fdjp230_--_JNCI_Journal_of_the_National_Cancer_Institute-57"><span>[</span>57<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Cytogenetic_profiles">Cytogenetic profiles</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=11" title="Edit section: Cytogenetic profiles">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Based on a series of 493 neuroblastoma samples, it has been reported that overall genomic pattern, as tested by <a href="/wiki/Virtual_Karyotype" title="Virtual Karyotype" class="mw-redirect">array-based karyotyping</a>, is a predictor of outcome in neuroblastoma:<sup id="cite_ref-pmid19171713_58-0" class="reference"><a href="#cite_note-pmid19171713-58"><span>[</span>58<span>]</span></a></sup></p>
<ul>
<li>Tumors presenting exclusively with whole chromosome copy number changes were associated with excellent survival.</li>
<li>Tumors presenting with any kind of segmental chromosome copy number changes were associated with a high risk of relapse.</li>
<li>Within tumors showing segmental alterations, additional independent predictors of decreased overall survival were <a href="/wiki/N-myc" title="N-myc" class="mw-redirect">N-myc</a> amplification, 1p and 11q deletions, and 1q gain.</li>
</ul>
<p>Earlier publications categorized neuroblastomas into three major subtypes based on cytogenetic profiles:<sup id="cite_ref-59" class="reference"><a href="#cite_note-59"><span>[</span>59<span>]</span></a></sup><sup id="cite_ref-60" class="reference"><a href="#cite_note-60"><span>[</span>60<span>]</span></a></sup></p>
<ul>
<li>Subtype 1: favorable neuroblastoma with near triploidy and a predominance of numerical gains and losses, mostly representing non-metastatic NB stages 1, 2 and 4S.</li>
<li>Subtypes 2A and 2B: found in unfavorable widespread neuroblastoma, stages 3 and 4, with 11q loss and 17q gain without N-myc amplification (subtype 2A) or with N-myc amplification often together with 1p deletions and 17q gain (subtype 2B).</li>
</ul>
<p><a href="/wiki/Virtual_Karyotype" title="Virtual Karyotype" class="mw-redirect">Virtual karyotyping</a> can be performed on fresh or paraffin-embedded tumors to assess copy number at these loci. SNP array virtual karyotyping is preferred for tumor samples, including neuroblastomas, because they can detect copy neutral loss of heterozygosity (acquired uniparental disomy). Copy neutral LOH can be biologically equivalent to a deletion and has been detected at key loci in neuroblastoma.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61"><span>[</span>61<span>]</span></a></sup> ArrayCGH, FISH, or conventional cytogenetics cannot detect copy neutral LOH.</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=12" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Neuroblastoma comprises 6-10% of all childhood cancers, and 15% of cancer deaths in children. The annual mortality rate is 10 per million children in the 0- to 4-year-old age group, and 4 per million in the 4- to 9-year old age group.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62"><span>[</span>62<span>]</span></a></sup></p>
<p>The highest incidence is in the first year of life, and some cases are <a href="/wiki/Congenital" title="Congenital" class="mw-redirect">congenital</a>. The age range is broad, including older children and adults,<sup id="cite_ref-pmid9149032_63-0" class="reference"><a href="#cite_note-pmid9149032-63"><span>[</span>63<span>]</span></a></sup> but only 10% of cases occur in people older than 5 years of age.<sup id="cite_ref-pmid17544628_23-1" class="reference"><a href="#cite_note-pmid17544628-23"><span>[</span>23<span>]</span></a></sup> A large European study reported less than 2% of over 4000 neuroblastoma cases were over 18 years old.<sup id="cite_ref-pmid18545256_64-0" class="reference"><a href="#cite_note-pmid18545256-64"><span>[</span>64<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=13" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Rudolf_Virchow.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/80/Rudolf_Virchow.jpg/220px-Rudolf_Virchow.jpg" width="220" height="270" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/80/Rudolf_Virchow.jpg/330px-Rudolf_Virchow.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/80/Rudolf_Virchow.jpg/440px-Rudolf_Virchow.jpg 2x" data-file-width="1251" data-file-height="1536" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Rudolf_Virchow.jpg" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Rudolf_Virchow" title="Rudolf Virchow">Rudolf Virchow</a>: the first to describe an abdominal tumor in a child as a "glioma"</div>
</div>
</div>
<p>In 1864 German physician <a href="/wiki/Rudolf_Virchow" title="Rudolf Virchow">Rudolf Virchow</a> was the first to describe an abdominal tumor in a child as a "glioma". The characteristics of tumors from the sympathetic nervous system and the adrenal medulla were then noted in 1891 by German pathologist <a href="/wiki/Felix_Jacob_Marchand" title="Felix Jacob Marchand">Felix Marchand</a>.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65"><span>[</span>65<span>]</span></a></sup> <sup id="cite_ref-urlIn_Situ_Neuroblastomas:_a_Contribution_to_the_Natural_History_of_Neural_Crest_Tumors_66-0" class="reference"><a href="#cite_note-urlIn_Situ_Neuroblastomas:_a_Contribution_to_the_Natural_History_of_Neural_Crest_Tumors-66"><span>[</span>66<span>]</span></a></sup> In 1901 the distinctive presentation of stage 4S in infants (liver but no bone metastases) was described by William Pepper. In 1910 <a href="/wiki/James_Homer_Wright" title="James Homer Wright">James Homer Wright</a> understood the tumor to originate from primitive neural cells, and named it neuroblastoma. He also noted the circular clumps of cells in bone marrow samples which are now termed "Homer-Wright pseudorosettes".<sup id="cite_ref-pmid19034443_67-0" class="reference"><a href="#cite_note-pmid19034443-67"><span>[</span>67<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Society_and_culture">Society and culture</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=14" title="Edit section: Society and culture">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Legislative_efforts">Legislative efforts</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=15" title="Edit section: Legislative efforts">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/U.S._Representative" title="U.S. Representative" class="mw-redirect">U.S. Representative</a> <a href="/wiki/Chet_Edwards" title="Chet Edwards">Chet Edwards</a> of <a href="/wiki/Waco,_Texas" title="Waco, Texas">Waco</a>, <a href="/wiki/Texas" title="Texas">Texas</a>, successfully introduced legislation to earmark $150 million toward a cure for neuroblastoma and other cancers. The measure was signed into law in July 2008 by <a href="/wiki/U.S._President" title="U.S. President" class="mw-redirect">U.S. President</a> <a href="/wiki/George_W._Bush" title="George W. Bush">George W. Bush</a>. Edwards was inspired in the endeavor by the illness and subsequent death of Erin Channing Buenger (1997–2009) of <a href="/wiki/Bryan,_Texas" title="Bryan, Texas">Bryan</a>, daughter of one of his constituents, <a href="/wiki/Walter_L._Buenger" title="Walter L. Buenger">Walter L. Buenger</a>, head of the history department at <a href="/wiki/Texas_A%26M_University" title="Texas A&amp;M University">Texas A&amp;M University</a>.<sup id="cite_ref-eagle_68-0" class="reference"><a href="#cite_note-eagle-68"><span>[</span>68<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Fundraising">Fundraising</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=16" title="Edit section: Fundraising">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Several organizations fundraise for research into neuroblastoma. GLOBAL VISION cancer care NGO a pioneer non profit organisation in India supporting poor cancer patients since 2009 <a rel="nofollow" class="external autonumber" href="http://www.ngoglobalvision.org">[2]</a>. <a href="/wiki/Tom_Hanks" title="Tom Hanks">Tom Hanks</a> is the Honorary Patron of the <a rel="nofollow" class="external text" href="http://www.jamesfund.com/">James Fund</a>, a leading fundraising organization in support of clinical research. On December 31, 2014, <a rel="nofollow" class="external text" href="http://www.sickkidsfoundation.com/">SickKids Foundation</a> takes over stewardship of The James Funds. The Cincinnati Bengals announced in 2014 that they would donate proceeds from the jersey sales of defensive lineman Devon Still's jersey to the Cincinnati Children's Hospital, and will present a check from more than $1.3 million to Still's daughter Leah during Thursday night's game on November 6, 2014. Cincinnati Bengals defensive lineman Devon Still's jersey is the 11th-most popular in the NFL</p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=17" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Treatments">Treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=18" title="Edit section: Treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Recent focus has been to reduce therapy for low and intermediate risk neuroblastoma while maintaining survival rates at 90%.<sup id="cite_ref-titleNeuroblastoma_Committee_-_Current_Focus_of_Research_69-0" class="reference"><a href="#cite_note-titleNeuroblastoma_Committee_-_Current_Focus_of_Research-69"><span>[</span>69<span>]</span></a></sup> A study of 467 intermediate risk patients enrolled in A3961 from 1997 to 2005 confirmed the hypothesis that therapy could be successfully reduced for this risk group. Those with favorable characteristics (tumor grade and response) received four cycles of chemotherapy, and those with unfavorable characteristics received eight cycles, with three-year event free survival and overall survival stable at 90% for the entire cohort. Future plans are to intensify treatment for those patients with aberration of 1p36 or 11q23 chromosomes as well as for those who lack early response to treatment.<sup id="cite_ref-urlA_phase_III_trial_of_biologically-based_therapy_reduction_for_intermediate_risk_neuroblastoma_--_Baker_et_al._25_.2818_Supplement.29:_9504_--_ASCO_Meeting_Abstracts_70-0" class="reference"><a href="#cite_note-urlA_phase_III_trial_of_biologically-based_therapy_reduction_for_intermediate_risk_neuroblastoma_--_Baker_et_al._25_.2818_Supplement.29:_9504_--_ASCO_Meeting_Abstracts-70"><span>[</span>70<span>]</span></a></sup><sup id="cite_ref-pmid20879880_71-0" class="reference"><a href="#cite_note-pmid20879880-71"><span>[</span>71<span>]</span></a></sup></p>
<p>By contrast, focus the past 20 years or more has been to intensify treatment for high-risk neuroblastoma. Chemotherapy induction variations, timing of surgery, stem cell transplant regimens, various delivery schemes for radiation, and use of monoclonal antibodies and retinoids to treat minimal residual disease continue to be examined. Recent phase III <a href="/wiki/Clinical_trials" title="Clinical trials" class="mw-redirect">clinical trials</a> with randomization have been carried out to answer these questions to improve survival of high-risk disease:</p>
<ul>
<li>1982-1985: European Neuroblastoma Study Group (ENSG1) enrolled 167 children and randomized to melphalan autologous bone marrow transplant or no further therapy (no radiation therapy given to any). Transplant and no-transplant arms each had 65 patients, and recent long-term follow-up report revealed significantly better 5 year event-free survival for stage 4 over 1 year old in melphalan-transplant group versus no further treatment: 33% versus 17% respectively.<sup id="cite_ref-pmid15546135_72-0" class="reference"><a href="#cite_note-pmid15546135-72"><span>[</span>72<span>]</span></a></sup></li>
<li>1990-1999: European study (EU-20592 or CCLGNB-1990-11) randomized 262 high-risk children over 1 year old and revealed higher survival rate for rapid sequence induction (10-day cycle) versus standard induction (21-day cycle) with same total dose. Ten-year event free survival was 27% and 18% respectively with non-aggressive surgical approach, no radiotherapy, and melphalan-only autologous bone marrow or stem cell transplant for both groups.<sup id="cite_ref-pmid18308250_73-0" class="reference"><a href="#cite_note-pmid18308250-73"><span>[</span>73<span>]</span></a></sup></li>
<li>1991-1996: Phase III trial with two sequential randomizations for 379 high-risk NB patients was carried out by the Children's Cancer Group (CCG-3891) which demonstrated improved survival with myeloablative therapy (with total body irradiation) and 13-cis-retinoic acid (Accutane) with 50 patients in each of the four arms of the study.,<sup id="cite_ref-74" class="reference"><a href="#cite_note-74"><span>[</span>74<span>]</span></a></sup><sup id="cite_ref-pmid19171716_75-0" class="reference"><a href="#cite_note-pmid19171716-75"><span>[</span>75<span>]</span></a></sup></li>
<li>1996-2003: The German (GPOH) study NB97 compared outcomes of 295 high-risk NB patients randomized for stem cell transplant or consolidation chemotherapy. Results showed increased survival with transplant.<sup id="cite_ref-76" class="reference"><a href="#cite_note-76"><span>[</span>76<span>]</span></a></sup></li>
<li>2000-2006: The recent study (COG-A3973)<sup id="cite_ref-titleClinical_Trials_.28PDQ.EF.BF.BD.29_-_National_Cancer_Institute_77-0" class="reference"><a href="#cite_note-titleClinical_Trials_.28PDQ.EF.BF.BD.29_-_National_Cancer_Institute-77"><span>[</span>77<span>]</span></a></sup> questioned the need for purged stem cells for CEM-LI (carboplatin, etoposide, melphalan, with local irradiation)<sup id="cite_ref-Autologous_Stem_Cell_Transplantation_for_High-Risk_Neuroblastoma_78-0" class="reference"><a href="#cite_note-Autologous_Stem_Cell_Transplantation_for_High-Risk_Neuroblastoma-78"><span>[</span>78<span>]</span></a></sup> transplant, and accrued 486 patients. Purging stem cells was not found to improve survival<sup id="cite_ref-titleResponse_and_toxicity_to_a_dose-intensive_multi-agent_chemotherapy_induction_regimen_for_high_risk_neuroblastoma_.28HR-NB.29:_A_Childrens_Oncology_Group_.28COG_A3973.29_study._-_ASCO_51-1" class="reference"><a href="#cite_note-titleResponse_and_toxicity_to_a_dose-intensive_multi-agent_chemotherapy_induction_regimen_for_high_risk_neuroblastoma_.28HR-NB.29:_A_Childrens_Oncology_Group_.28COG_A3973.29_study._-_ASCO-51"><span>[</span>51<span>]</span></a></sup></li>
<li>2000-2012: A concurrent study (COG-ANBL0032)<sup id="cite_ref-titleNational_Cancer_Institute_-_Clinical_79-0" class="reference"><a href="#cite_note-titleNational_Cancer_Institute_-_Clinical-79"><span>[</span>79<span>]</span></a></sup> determined in early review that the antibody ch14.18 with <a href="/wiki/Interleukin_2" title="Interleukin 2">interleukin 2</a> and <a href="/wiki/GMCSF" title="GMCSF" class="mw-redirect">GMCSF</a> (studied retrospectively in German GPOH NB90 and NB 97 at a lower dose and without <a href="/wiki/Cytokines" title="Cytokines" class="mw-redirect">cytokines</a><sup id="cite_ref-titleConsolidation_Treatment_With_Chimeric_Anti-GD2-Antibody_ch14.18_in_Children_Older_Than_1_Year_With_Metastatic_Neuroblastoma_--_Simon_et_al._22_.2817.29:_3549_--_Journal_of_Clinical_Oncology_80-0" class="reference"><a href="#cite_note-titleConsolidation_Treatment_With_Chimeric_Anti-GD2-Antibody_ch14.18_in_Children_Older_Than_1_Year_With_Metastatic_Neuroblastoma_--_Simon_et_al._22_.2817.29:_3549_--_Journal_of_Clinical_Oncology-80"><span>[</span>80<span>]</span></a></sup>) improved survival, and will accrue a total of 423 patients.<sup id="cite_ref-urlNCI_Cancer_Bulletin_for_May_19.2C_2009_-_National_Cancer_Institute_81-0" class="reference"><a href="#cite_note-urlNCI_Cancer_Bulletin_for_May_19.2C_2009_-_National_Cancer_Institute-81"><span>[</span>81<span>]</span></a></sup> A follow on Phase III study COG-ANBL0931 opened Jan 2010 to accrue 105 patients to gather further safety and efficacy data for FDA approval.<sup id="cite_ref-urlMonoclonal_Antibody_Ch14.18.2C_Sargramostim.2C_Aldesleukin.2C_and_Isotretinoin_After_Autologous_Stem_Cell_Transplant_in_Treating_Patients_With_Neuroblastoma_-_Full_Text_View_-_ClinicalTrials.gov_82-0" class="reference"><a href="#cite_note-urlMonoclonal_Antibody_Ch14.18.2C_Sargramostim.2C_Aldesleukin.2C_and_Isotretinoin_After_Autologous_Stem_Cell_Transplant_in_Treating_Patients_With_Neuroblastoma_-_Full_Text_View_-_ClinicalTrials.gov-82"><span>[</span>82<span>]</span></a></sup></li>
<li>2002-2008: SIOP (International Society of Paediatric Oncology) formed the European SIOP Neuroblastoma Group (SIOPEN) in 1994 <sup id="cite_ref-SIOP_Neuroblastoma_Education_Book_83-0" class="reference"><a href="#cite_note-SIOP_Neuroblastoma_Education_Book-83"><span>[</span>83<span>]</span></a></sup> and activated a phase III high-risk NB protocol in 2002 (SIOP-EUROPE-HR-NBL-1) <sup id="cite_ref-titleTrials_-_National_Cancer_Institute_84-0" class="reference"><a href="#cite_note-titleTrials_-_National_Cancer_Institute-84"><span>[</span>84<span>]</span></a></sup> using "rapid" COJEC (8 cycles of chemotherapy given at 10-day intervals) followed by transplant randomization to CEM (carboplatin, etoposide, melphalan) or BuMel (busulfan, melphalan) and the study has been recently amended to randomize children to ch14.18 antibody treatment with or without subcutaneous IL2 (without GM-CSF as given in the COG). This study recently reported the benefit of growth factors (GCSF),<sup id="cite_ref-pmid20567002_85-0" class="reference"><a href="#cite_note-pmid20567002-85"><span>[</span>85<span>]</span></a></sup> and all patients receive retinoic acid. This trial will accrue 1000 patients (175 per year).</li>
<li>2005-2010: The current German NB2004 <sup id="cite_ref-urlObservation.2C_Combination_Chemotherapy.2C_Radiation_Therapy.2C_and.2For_Autologous_Stem_Cell_Transplant_in_Treating_Young_Patients_With_Neuroblastoma_-_Full_Text_View_-_ClinicalTrials.gov_86-0" class="reference"><a href="#cite_note-urlObservation.2C_Combination_Chemotherapy.2C_Radiation_Therapy.2C_and.2For_Autologous_Stem_Cell_Transplant_in_Treating_Young_Patients_With_Neuroblastoma_-_Full_Text_View_-_ClinicalTrials.gov-86"><span>[</span>86<span>]</span></a></sup> randomization will include MIBG therapy and randomize topotecan use in up-front therapy and will accrue a total of 642 for all risk groups (roughly half will be high-risk). After transplant, the high-risk protocol includes six months of cis-retinoic acid, a three-month break, and another three months of retinoic acid.</li>
<li>2007: The COG phase III ANBL0532 <sup id="cite_ref-urlClinical_Trials_.28PDQ.C2.AE.29_-_National_Cancer_Institute_87-0" class="reference"><a href="#cite_note-urlClinical_Trials_.28PDQ.C2.AE.29_-_National_Cancer_Institute-87"><span>[</span>87<span>]</span></a></sup> trial opened December 2007 for accrual of 495 and will compare single versus tandem transplants, and induction begins with two cycles of topotecan.<sup id="cite_ref-88" class="reference"><a href="#cite_note-88"><span>[</span>88<span>]</span></a></sup></li>
</ul>
<p>In addition to these phase III studies, some research institutions offer pilot treatment protocols. For example, St Jude's recently finished (2007) testing a new up-front chemotherapy regimen in 23 children which included <a href="/wiki/Irinotecan" title="Irinotecan">irinotecan</a> and <a href="/wiki/Gefitinib" title="Gefitinib">gefitinib</a> with 16 months of maintenance chemotherapy after stem cell transplant with alternating oral 13-cis-retinoic acid and <a href="/wiki/Topotecan" title="Topotecan">topotecan</a>.<sup id="cite_ref-titleNeuroblastoma_Protocol_2005:_Therapy_for_Children_with_Advanced_Stage_High-Risk_Neuroblastoma_89-0" class="reference"><a href="#cite_note-titleNeuroblastoma_Protocol_2005:_Therapy_for_Children_with_Advanced_Stage_High-Risk_Neuroblastoma-89"><span>[</span>89<span>]</span></a></sup> Memorial Sloan-Kettering Cancer Center in New York offers treatment that includes a mouse-derived monoclonal antibody, <a href="/wiki/3F8" title="3F8">3F8</a>, used in protocols since the mid-1980s. This antibody is used for treating minimal residual disease or consolidation instead of stem cell transplant.<sup id="cite_ref-titleSloan-Kettering_-_Neuroblastoma:_Our_Clinical_Trials_90-0" class="reference"><a href="#cite_note-titleSloan-Kettering_-_Neuroblastoma:_Our_Clinical_Trials-90"><span>[</span>90<span>]</span></a></sup> A new pilot protocol COG-ANBL09P1 available for newly diagnosed (high-risk) children at several Children's Oncology Group (COG) centers will offer MIBG radiotherapy and chemotherapy for the transplant regimen.<sup id="cite_ref-urlInduction_Therapy_Followed_by_131_I-MIBG_and_High-Dose_Chemotherapy_in_Treating_Patients_With_Newly_Diagnosed_High-Risk_Neuroblastoma_Undergoing_Stem_Cell_Transplant.2C_Radiation_Therapy.2C_and_Maintenance_Therapy_With_Isotretinoin_-_Full_Text_View_-_ClinicalTrials.gov_91-0" class="reference"><a href="#cite_note-urlInduction_Therapy_Followed_by_131_I-MIBG_and_High-Dose_Chemotherapy_in_Treating_Patients_With_Newly_Diagnosed_High-Risk_Neuroblastoma_Undergoing_Stem_Cell_Transplant.2C_Radiation_Therapy.2C_and_Maintenance_Therapy_With_Isotretinoin_-_Full_Text_View_-_ClinicalTrials.gov-91"><span>[</span>91<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Refractory_and_relapsed_neuroblastoma">Refractory and relapsed neuroblastoma</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=19" title="Edit section: Refractory and relapsed neuroblastoma">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:BiggeggSH-SY5Y.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e7/BiggeggSH-SY5Y.jpg/220px-BiggeggSH-SY5Y.jpg" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e7/BiggeggSH-SY5Y.jpg/330px-BiggeggSH-SY5Y.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e7/BiggeggSH-SY5Y.jpg/440px-BiggeggSH-SY5Y.jpg 2x" data-file-width="1600" data-file-height="1200" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:BiggeggSH-SY5Y.jpg" class="internal" title="Enlarge"></a></div>
microscopic view of a NB cell line (SH-SY5Y) used in preclinical research for testing new agents</div>
</div>
</div>
<p>Some children (particularly in high-risk cases) do not respond completely to frontline treatment (with a complete response or very good partial response) and are labeled refractory. These children are removed from the frontline therapy (clinical trial) and are eligible for clinical trials using new therapies. Many high-risk children have a good response to frontline therapy and achieve a remission, but later the disease recurs (relapse). These children are also eligible for new therapies being tested in clinical trials.</p>
<p>Chemotherapy with topotecan and cyclophosphamide is frequently used in refractory setting and after relapse. A randomized study (2004) with 119 patients (comparing topotecan alone to topotecan and cyclophosphamide) revealed a 31% complete or partial response rate with two-year progression-free survival at 36% in the topotecan and cyclophosphamide group.<sup id="cite_ref-titleRecurrent_neuroblastoma:_Randomized_treatment_with_topotecan_.2B_cyclophosphamide_.28T.2BC.29_vs._topotecan_alone.28T.29._A_POG.2FCCG_Intergroup_Study_--_Frantz_et_al._22_.2814_Supplement.29:_8512_--_ASCO_Meeting_Abstracts_92-0" class="reference"><a href="#cite_note-titleRecurrent_neuroblastoma:_Randomized_treatment_with_topotecan_.2B_cyclophosphamide_.28T.2BC.29_vs._topotecan_alone.28T.29._A_POG.2FCCG_Intergroup_Study_--_Frantz_et_al._22_.2814_Supplement.29:_8512_--_ASCO_Meeting_Abstracts-92"><span>[</span>92<span>]</span></a></sup> Irinotecan (intravenous or oral) and oral temozolomide are also used in refractory and recurrent neuroblastoma.<sup id="cite_ref-titleIrinotecan_Plus_Temozolomide_for_Relapsed_or_Refractory_Neuroblastoma_--_Kushner_et_al._24_.2833.29:_5271_--_Journal_of_Clinical_Oncology_93-0" class="reference"><a href="#cite_note-titleIrinotecan_Plus_Temozolomide_for_Relapsed_or_Refractory_Neuroblastoma_--_Kushner_et_al._24_.2833.29:_5271_--_Journal_of_Clinical_Oncology-93"><span>[</span>93<span>]</span></a></sup><sup id="cite_ref-titlePhase_I_study_of_oral_irinotecan_and_temozolomide_in_children_with_relapsed_high-risk_neuroblastoma:_A_New_Approach_to_Neuroblastoma_Therapy_.28NANT.29_Consortium_study_--_Wagner_et_al._25_.2818_Supplement.29:_9567_--_ASCO_Meeting_Abstracts_94-0" class="reference"><a href="#cite_note-titlePhase_I_study_of_oral_irinotecan_and_temozolomide_in_children_with_relapsed_high-risk_neuroblastoma:_A_New_Approach_to_Neuroblastoma_Therapy_.28NANT.29_Consortium_study_--_Wagner_et_al._25_.2818_Supplement.29:_9567_--_ASCO_Meeting_Abstracts-94"><span>[</span>94<span>]</span></a></sup></p>
<p>Many phase I and phase II trials are currently testing new agents against neuroblastoma in children who have relapsed or are resistant to initial therapy. Investigators are currently studying new agents, alone and in new combinations, using small molecule <a href="/wiki/Targeted_therapy" title="Targeted therapy">targeted therapy</a>, 131-I MIBG radiation therapy, <a href="/wiki/Angiogenesis" title="Angiogenesis">angiogenesis</a> agents, new <a href="/wiki/Monoclonal_antibodies" title="Monoclonal antibodies" class="mw-redirect">monoclonal antibodies</a>, vaccines, oncolytic viruses, as well as new myeloablative regimens.</p>
<p>A group of 16 children's hospitals in the United States known as the New Advances in Neuroblastoma Therapy (NANT) consortium coordinates the I-131 MIBG radiation therapy trials. The NANT consortium also offers trials using an oral powder formulation of <a href="/wiki/Fenretinide" title="Fenretinide">fenretinide</a>, <a href="/wiki/Intravenous" title="Intravenous" class="mw-redirect">intravenous</a> fenretinide, <a href="/wiki/Bisphosphonate" title="Bisphosphonate">bisphosphonate</a> (Zometa) with other agents, and combining I-131 MIBG with the inhibitor <a href="/wiki/Vorinostat" title="Vorinostat">vorinostat</a>.<sup id="cite_ref-titleNANT_Home_Page_95-0" class="reference"><a href="#cite_note-titleNANT_Home_Page-95"><span>[</span>95<span>]</span></a></sup></p>
<p>Other research study groups such as The Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) also conduct clinical trials to treat relapse neuroblastoma.<sup id="cite_ref-urlHome_-_Neuroblastoma_and_Medulloblastoma_Translational_Research_Consortium_96-0" class="reference"><a href="#cite_note-urlHome_-_Neuroblastoma_and_Medulloblastoma_Translational_Research_Consortium-96"><span>[</span>96<span>]</span></a></sup> Institutions in Europe are studying novel therapies to treat relapse, including haploidentical stem cell transplant.<sup id="cite_ref-urlHaploidentical_Stem_Cell_Transplantation_in_Neuroblastoma_-_Full_Text_View_-_ClinicalTrials.gov_97-0" class="reference"><a href="#cite_note-urlHaploidentical_Stem_Cell_Transplantation_in_Neuroblastoma_-_Full_Text_View_-_ClinicalTrials.gov-97"><span>[</span>97<span>]</span></a></sup> Many hospitals conduct their own institutional studies as well.</p>
<p>The protein <a href="/wiki/P53_(protein)" title="P53 (protein)" class="mw-redirect">p53</a> is believed to play a role in the development of resistance to chemotherapy.<sup id="cite_ref-pmid17974978_98-0" class="reference"><a href="#cite_note-pmid17974978-98"><span>[</span>98<span>]</span></a></sup> A November 2009 study in mice shows that activating the tumor suppressor p53 with a new drug, nutlin-3, may slow tumor growth.<sup id="cite_ref-pmid19903807_99-0" class="reference"><a href="#cite_note-pmid19903807-99"><span>[</span>99<span>]</span></a></sup> In this study, physician Tom Van Maerken of <a href="/wiki/Ghent_University_Hospital" title="Ghent University Hospital">Ghent University Hospital</a> in Belgium and his colleagues used nutlin-3 to neutralize MDM2, a protein that binds to the p53 protein and obstructs p53's ability to trigger programmed cell death. Earlier studies have shown that nutlin-3 can specifically prevent MDM2 from disabling p53.</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=20" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 32em; -webkit-column-width: 32em; column-width: 32em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-titleeMedicine_-_Neuroblastoma_:_Article_by_Norman_J_Lacayo.2C_MD-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleeMedicine_-_Neuroblastoma_:_Article_by_Norman_J_Lacayo.2C_MD_1-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.emedicine.com/ped/topic1570.htm">"eMedicine - Neuroblastoma&#160;: Article by Norman J Lacayo, MD"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-07-30</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=eMedicine+-+Neuroblastoma+%3A+Article+by+Norman+J+Lacayo%2C+MD&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.emedicine.com%2Fped%2Ftopic1570.htm&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.nhs.uk/conditions/Neuroblastoma/Pages/Introduction.aspx">NHS Website</a></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text">Janet Sassi, <a rel="nofollow" class="external text" href="http://www.fordham.edu/campus_resources/public_affairs/inside_fordham/february_16_2007/in_focus_faculty_and/cellular_communicati_24950.asp">"Cellular Communication: Unraveling the Secrets of Histone Proteins"</a>, Fordham University, February 16, 2007</span></li>
<li id="cite_note-pmid19383347-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19383347_4-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bénard J, Raguénez G, Kauffmann A, Valent A, Ripoche H, Joulin V, Job B, Danglot G, Cantais S, Robert T, Terrier-Lacombe MJ, Chassevent A, Koscielny S, Fischer M, Berthold F, Lipinski M, Tursz T, Dessen P, Lazar V, Valteau-Couanet D (October 2008). "MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S". <i>Mol Oncol</i> <b>2</b> (3): 261–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.molonc.2008.07.002">10.1016/j.molonc.2008.07.002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19383347">19383347</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=MYCN-non-amplified+metastatic+neuroblastoma+with+good+prognosis+and+spontaneous+regression%3A+a+molecular+portrait+of+stage+4S&amp;rft.au=B%C3%A9nard+J%2C+Ragu%C3%A9nez+G%2C+Kauffmann+A%2C+Valent+A%2C+Ripoche+H%2C+Joulin+V%2C+Job+B%2C+Danglot+G%2C+Cantais+S%2C+Robert+T%2C+Terrier-Lacombe+MJ%2C+Chassevent+A%2C+Koscielny+S%2C+Fischer+M%2C+Berthold+F%2C+Lipinski+M%2C+Tursz+T%2C+Dessen+P%2C+Lazar+V%2C+Valteau-Couanet+D&amp;rft.aulast=B%C3%A9nard+J%2C+Ragu%C3%A9nez+G%2C+Kauffmann+A%2C+Valent+A%2C+Ripoche+H%2C+Joulin+V%2C+Job+B%2C+Danglot+G%2C+Cantais+S%2C+Robert+T%2C+Terrier-Lacombe+MJ%2C+Chassevent+A%2C+Koscielny+S%2C+Fischer+M%2C+Berthold+F%2C+Lipinski+M%2C+Tursz+T%2C+Dessen+P%2C+Lazar+V%2C+Valteau-Couanet+D&amp;rft.date=October+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.molonc.2008.07.002&amp;rft_id=info%3Apmid%2F19383347&amp;rft.issue=3&amp;rft.jtitle=Mol+Oncol&amp;rft.pages=261-71&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlScienceDirect_-_The_Lancet_:_Neuroblastoma-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlScienceDirect_-_The_Lancet_:_Neuroblastoma_5-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007). "Neuroblastoma". <i>The Lancet</i> <b>369</b> (9579): 2106–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2807%2960983-0">10.1016/S0140-6736(07)60983-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17586306">17586306</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Neuroblastoma&amp;rft.aulast=Maris+JM%2C+Hogarty+MD%2C+Bagatell+R%2C+Cohn+SL&amp;rft.au=Maris+JM%2C+Hogarty+MD%2C+Bagatell+R%2C+Cohn+SL&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2807%2960983-0&amp;rft_id=info%3Apmid%2F17586306&amp;rft.issue=9579&amp;rft.jtitle=The+Lancet&amp;rft.pages=2106-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=369" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleeMedicine_-_Esthesioneuroblastoma_:_Article_by_Pavel_Dulguerov.2C_MD-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleeMedicine_-_Esthesioneuroblastoma_:_Article_by_Pavel_Dulguerov.2C_MD_6-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic748.htm">"eMedicine - Esthesioneuroblastoma&#160;: Article by Pavel Dulguerov, MD"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-07-30</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=eMedicine+-+Esthesioneuroblastoma+%3A+Article+by+Pavel+Dulguerov%2C+MD&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.emedicine.com%2Fmed%2Ftopic748.htm&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><span class="citation book">Cheung, Nai-Kong (2005). <i>Neuroblastoma</i>. p. 73. <a href="/wiki/Springer-Verlag" title="Springer-Verlag" class="mw-redirect">Springer-Verlag</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/3-540-40841-X" title="Special:BookSources/3-540-40841-X">3-540-40841-X</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.au=Cheung%2C+Nai-Kong&amp;rft.aufirst=Nai-Kong&amp;rft.aulast=Cheung&amp;rft.btitle=Neuroblastoma&amp;rft.date=2005&amp;rft.genre=book&amp;rft.isbn=3-540-40841-X&amp;rft.pub=Springer-Verlag&amp;rft.series=p.+73&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleNeuroblastoma_in_children_:_Cancerbackup-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleNeuroblastoma_in_children_:_Cancerbackup_8-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancerbackup.org.uk/cancertype/childrenscancers/typesofchildrenscancers/neuroblastoma#9216">"Neuroblastoma in children&#160;: Cancerbackup"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-01-01</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Neuroblastoma+in+children+%3A+Cancerbackup&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancerbackup.org.uk%2Fcancertype%2Fchildrenscancers%2Ftypesofchildrenscancers%2Fneuroblastoma%239216&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleNeuroblastoma:_Pediatric_Cancers:_Merck_Manual_Professional-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleNeuroblastoma:_Pediatric_Cancers:_Merck_Manual_Professional_9-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.merck.com/mmpe/sec19/ch285/ch285b.html">"Neuroblastoma: Pediatric Cancers: Merck Manual Professional"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-01-01</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Neuroblastoma%3A+Pediatric+Cancers%3A+Merck+Manual+Professional&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.merck.com%2Fmmpe%2Fsec19%2Fch285%2Fch285b.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17943963-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17943963_10-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Friedman GK, Castleberry RP (December 2007). "Changing trends of research and treatment in infant neuroblastoma". <i>Pediatr Blood Cancer</i> <b>49</b> (7 Suppl): 1060–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fpbc.21354">10.1002/pbc.21354</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17943963">17943963</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Changing+trends+of+research+and+treatment+in+infant+neuroblastoma&amp;rft.au=Friedman+GK%2C+Castleberry+RP&amp;rft.aulast=Friedman+GK%2C+Castleberry+RP&amp;rft.date=December+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fpbc.21354&amp;rft_id=info%3Apmid%2F17943963&amp;rft.issue=7+Suppl&amp;rft.jtitle=Pediatr+Blood+Cancer&amp;rft.pages=1060-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=49" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19430769-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19430769_11-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rothenberg AB, Berdon WE, D'Angio GJ, Yamashiro DJ, Cowles RA (July 2009). "The association between neuroblastoma and opsoclonus-myoclonus syndrome: a historical review". <i>Pediatr Radiol</i> <b>39</b> (7): 723–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00247-009-1282-x">10.1007/s00247-009-1282-x</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0301-0449">0301-0449</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19430769">19430769</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=The+association+between+neuroblastoma+and+opsoclonus-myoclonus+syndrome%3A+a+historical+review&amp;rft.aulast=Rothenberg+AB%2C+Berdon+WE%2C+D%27Angio+GJ%2C+Yamashiro+DJ%2C+Cowles+RA&amp;rft.au=Rothenberg+AB%2C+Berdon+WE%2C+D%27Angio+GJ%2C+Yamashiro+DJ%2C+Cowles+RA&amp;rft.date=July+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00247-009-1282-x&amp;rft_id=info%3Apmid%2F19430769&amp;rft.issn=0301-0449&amp;rft.issue=7&amp;rft.jtitle=Pediatr+Radiol&amp;rft.pages=723-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=39" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation book">Cheung, Nai-Kong (2005). <i>Neuroblastoma</i>. p. 66-67. <a href="/wiki/Springer-Verlag" title="Springer-Verlag" class="mw-redirect">Springer-Verlag</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/3-540-40841-X" title="Special:BookSources/3-540-40841-X">3-540-40841-X</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.au=Cheung%2C+Nai-Kong&amp;rft.aufirst=Nai-Kong&amp;rft.aulast=Cheung&amp;rft.btitle=Neuroblastoma&amp;rft.date=2005&amp;rft.genre=book&amp;rft.isbn=3-540-40841-X&amp;rft.pub=Springer-Verlag&amp;rft.series=p.+66-67&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18724359-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18724359_13-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Mossé YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, Laquaglia MJ, Sennett R, Lynch JE, Perri P, Laureys G, Speleman F, Kim C, Hou C, Hakonarson H, Torkamani A, Schork NJ, Brodeur GM, Tonini GP, Rappaport E, Devoto M, Maris JM (October 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2672043">"Identification of ALK as a major familial neuroblastoma predisposition gene"</a>. <i>Nature</i> <b>455</b> (7215): 930–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnature07261">10.1038/nature07261</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2672043">2672043</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18724359">18724359</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Identification+of+ALK+as+a+major+familial+neuroblastoma+predisposition+gene&amp;rft.aulast=Moss%C3%A9+YP%2C+Laudenslager+M%2C+Longo+L%2C+Cole+KA%2C+Wood+A%2C+Attiyeh+EF%2C+Laquaglia+MJ%2C+Sennett+R%2C+Lynch+JE%2C+Perri+P%2C+Laureys+G%2C+Speleman+F%2C+Kim+C%2C+Hou+C%2C+Hakonarson+H%2C+Torkamani+A%2C+Schork+NJ%2C+Brodeur+GM%2C+Tonini+GP%2C+Rappaport+E%2C+Devoto+M%2C+Maris+JM&amp;rft.au=Moss%C3%A9+YP%2C+Laudenslager+M%2C+Longo+L%2C+Cole+KA%2C+Wood+A%2C+Attiyeh+EF%2C+Laquaglia+MJ%2C+Sennett+R%2C+Lynch+JE%2C+Perri+P%2C+Laureys+G%2C+Speleman+F%2C+Kim+C%2C+Hou+C%2C+Hakonarson+H%2C+Torkamani+A%2C+Schork+NJ%2C+Brodeur+GM%2C+Tonini+GP%2C+Rappaport+E%2C+Devoto+M%2C+Maris+JM&amp;rft.date=October+2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2672043&amp;rft_id=info%3Adoi%2F10.1038%2Fnature07261&amp;rft_id=info%3Apmc%2F2672043&amp;rft_id=info%3Apmid%2F18724359&amp;rft.issue=7215&amp;rft.jtitle=Nature&amp;rft.pages=930-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=455" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation journal">Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984). "Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage". <i>Science</i> <b>224</b> (4653): 1121–1124. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1126%2Fscience.6719137">10.1126/science.6719137</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6719137">6719137</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Amplification+of+N-myc+in+untreated+human+neuroblastomas+correlates+with+advanced+disease+stage&amp;rft.au=Brodeur+GM%2C+Seeger+RC%2C+Schwab+M%2C+Varmus+HE%2C+Bishop+JM&amp;rft.aulast=Brodeur+GM%2C+Seeger+RC%2C+Schwab+M%2C+Varmus+HE%2C+Bishop+JM&amp;rft.date=1984&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.6719137&amp;rft_id=info%3Apmid%2F6719137&amp;rft.issue=4653&amp;rft.jtitle=Science&amp;rft.pages=1121-1124&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=224" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-lmo1_contributor-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-lmo1_contributor_15-0">^</a></b></span> <span class="reference-text"><span class="citation report"><a rel="nofollow" class="external text" href="http://www.newswise.com/articles/new-gene-for-childhood-cancer-neuroblastoma-is-discovered">New Gene For Childhood Cancer Neuroblastoma Is Discovered</a>. <i>NewsWise</i> (Report). November 2010.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=New+Gene+For+Childhood+Cancer+Neuroblastoma+Is+Discovered&amp;rft.date=November++2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.newswise.com%2Farticles%2Fnew-gene-for-childhood-cancer-neuroblastoma-is-discovered&amp;rft.jtitle=NewsWise&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text">Copy number variation at 1q21.1 associated with neuroblastoma; Diskin et al.; Nature 459, 987-991 (18 June 2009) | <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnature08035">10.1038/nature08035</a> <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19536264?dopt=Abstract">PMID 19536264</a>; Received 14 December 2008; Accepted 30 March 2009</span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text">Olshan, AF, Bunin, GR (2000) Epidemiology of Neuroblastoma. In: Brodeur, GM, Sawada, T, Tsuchida, Y, Voute, PA (eds.), Neuroblastoma, Elsevier, Amsterdam, pp. 33-39. <a href="/wiki/Special:BookSources/044450222X" class="internal mw-magiclink-isbn">ISBN 0-444-50222-X</a> <a rel="nofollow" class="external autonumber" href="http://us.elsevierhealth.com/product.jsp?isbn=9780444502223">[1]</a></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Menegaux F, Olshan AF, Neglia JP, Pollock BH, Bondy ML (May 2004). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2080646">"Day care, childhood infections, and risk of neuroblastoma"</a>. <i>Am. J. Epidemiol.</i> <b>159</b> (9): 843–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Faje%2Fkwh111">10.1093/aje/kwh111</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2080646">2080646</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15105177">15105177</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Day+care%2C+childhood+infections%2C+and+risk+of+neuroblastoma&amp;rft.aulast=Menegaux+F%2C+Olshan+AF%2C+Neglia+JP%2C+Pollock+BH%2C+Bondy+ML&amp;rft.au=Menegaux+F%2C+Olshan+AF%2C+Neglia+JP%2C+Pollock+BH%2C+Bondy+ML&amp;rft.date=May+2004&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2080646&amp;rft_id=info%3Adoi%2F10.1093%2Faje%2Fkwh111&amp;rft_id=info%3Apmc%2F2080646&amp;rft_id=info%3Apmid%2F15105177&amp;rft.issue=9&amp;rft.jtitle=Am.+J.+Epidemiol.&amp;rft.pages=843-51&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=159" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Olshan_et_al._1999-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-Olshan_et_al._1999_19-0">^</a></b></span> <span class="reference-text">Olshan AF,<i>et al.</i> <a rel="nofollow" class="external text" href="http://aje.oxfordjournals.org/cgi/content/abstract/150/9/930">"Hormone and Fertility Drug Use and the Risk of Neuroblastoma: A Report from the Children's Cancer Group and the Pediatric Oncology Group"</a>, Am J Epidemiol 1999;150:930-8.</span></li>
<li id="cite_note-McCall_EE.2C.27.27et_al..27.27_2005-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-McCall_EE.2C.27.27et_al..27.27_2005_20-0">^</a></b></span> <span class="reference-text"><span class="citation journal">McCall, E. E.; Olshan, A. F.; Daniels, J. L. (2005). "Maternal hair dye use and risk of neuroblastoma in offspring*". <i>Cancer Causes &amp; Control</i> <b>16</b> (6): 743. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs10552-005-1229-y">10.1007/s10552-005-1229-y</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Maternal+hair+dye+use+and+risk+of+neuroblastoma+in+offspring%2A&amp;rft.au=Daniels%2C+J.+L.&amp;rft.aufirst=E.+E.&amp;rft.aulast=McCall&amp;rft.au=McCall%2C+E.+E.&amp;rft.au=Olshan%2C+A.+F.&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs10552-005-1229-y&amp;rft.issue=6&amp;rft.jtitle=Cancer+Causes+%26+Control&amp;rft.pages=743&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19159399-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19159399_21-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Heck JE, Ritz B, Hung RJ, Hashibe M, Boffetta P (March 2009). "The epidemiology of neuroblastoma: a review". <i>Paediatr Perinat Epidemiol</i> <b>23</b> (2): 125–43. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-3016.2008.00983.x">10.1111/j.1365-3016.2008.00983.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19159399">19159399</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=The+epidemiology+of+neuroblastoma%3A+a+review&amp;rft.au=Heck+JE%2C+Ritz+B%2C+Hung+RJ%2C+Hashibe+M%2C+Boffetta+P&amp;rft.aulast=Heck+JE%2C+Ritz+B%2C+Hung+RJ%2C+Hashibe+M%2C+Boffetta+P&amp;rft.date=March+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-3016.2008.00983.x&amp;rft_id=info%3Apmid%2F19159399&amp;rft.issue=2&amp;rft.jtitle=Paediatr+Perinat+Epidemiol&amp;rft.pages=125-43&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16732582-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16732582_22-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Strenger V, Kerbl R, Dornbusch HJ, Ladenstein R, Ambros PF, Ambros IM, Urban C (2007). "Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients". <i>Pediatr Blood Cancer</i> <b>48</b> (5): 504–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fpbc.20888">10.1002/pbc.20888</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16732582">16732582</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Diagnostic+and+prognostic+impact+of+urinary+catecholamines+in+neuroblastoma+patients&amp;rft.aulast=Strenger+V%2C+Kerbl+R%2C+Dornbusch+HJ%2C+Ladenstein+R%2C+Ambros+PF%2C+Ambros+IM%2C+Urban+C&amp;rft.au=Strenger+V%2C+Kerbl+R%2C+Dornbusch+HJ%2C+Ladenstein+R%2C+Ambros+PF%2C+Ambros+IM%2C+Urban+C&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fpbc.20888&amp;rft_id=info%3Apmid%2F16732582&amp;rft.issue=5&amp;rft.jtitle=Pediatr+Blood+Cancer&amp;rft.pages=504-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=48" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17544628-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17544628_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17544628_23-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Howman-Giles R, Shaw PJ, Uren RF, Chung DK (2007). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S0001-2998(07)00030-X">"Neuroblastoma and other neuroendocrine tumors"</a>. <i>Semin Nucl Med</i> <b>37</b> (4): 286–302. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fj.semnuclmed.2007.02.009">10.1053/j.semnuclmed.2007.02.009</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17544628">17544628</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Neuroblastoma+and+other+neuroendocrine+tumors&amp;rft.au=Howman-Giles+R%2C+Shaw+PJ%2C+Uren+RF%2C+Chung+DK&amp;rft.aulast=Howman-Giles+R%2C+Shaw+PJ%2C+Uren+RF%2C+Chung+DK&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0001-2998%2807%2900030-X&amp;rft_id=info%3Adoi%2F10.1053%2Fj.semnuclmed.2007.02.009&amp;rft_id=info%3Apmid%2F17544628&amp;rft.issue=4&amp;rft.jtitle=Semin+Nucl+Med&amp;rft.pages=286-302&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=37" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15653652-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15653652_24-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pashankar FD, O'Dorisio MS, Menda Y (2005). <a rel="nofollow" class="external text" href="http://jnm.snmjournals.org/cgi/content/full/46/1_suppl/55S">"MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use"</a>. <i>Journal of Nuclear Medicine</i> <b>46</b> (1 (suppl)): 55S–61S. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15653652">15653652</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=MIBG+and+somatostatin+receptor+analogs+in+children%3A+current+concepts+on+diagnostic+and+therapeutic+use&amp;rft.aulast=Pashankar+FD%2C+O%27Dorisio+MS%2C+Menda+Y&amp;rft.au=Pashankar+FD%2C+O%27Dorisio+MS%2C+Menda+Y&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjnm.snmjournals.org%2Fcgi%2Fcontent%2Ffull%2F46%2F1_suppl%2F55S&amp;rft_id=info%3Apmid%2F15653652&amp;rft.issue=1+%28suppl%29&amp;rft.jtitle=Journal+of+Nuclear+Medicine&amp;rft.pages=55S-61S&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=46" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11844067-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11844067_25-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Miura K, Mineta H, Yokota N, Tsutsui Y (2001). <a rel="nofollow" class="external text" href="http://www.blackwell-synergy.com/openurl?genre=article&amp;sid=nlm:pubmed&amp;issn=1320-5463&amp;date=2001&amp;volume=51&amp;issue=12&amp;spage=942">"Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy"</a>. <i>Pathol. Int.</i> <b>51</b> (12): 942–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.1440-1827.2001.01300.x">10.1046/j.1440-1827.2001.01300.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11844067">11844067</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Olfactory+neuroblastoma+with+epithelial+and+endocrine+differentiation+transformed+into+ganglioneuroma+after+chemoradiotherapy&amp;rft.aulast=Miura+K%2C+Mineta+H%2C+Yokota+N%2C+Tsutsui+Y&amp;rft.au=Miura+K%2C+Mineta+H%2C+Yokota+N%2C+Tsutsui+Y&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.blackwell-synergy.com%2Fopenurl%3Fgenre%3Darticle%26sid%3Dnlm%3Apubmed%26issn%3D1320-5463%26date%3D2001%26volume%3D51%26issue%3D12%26spage%3D942&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1440-1827.2001.01300.x&amp;rft_id=info%3Apmid%2F11844067&amp;rft.issue=12&amp;rft.jtitle=Pathol.+Int.&amp;rft.pages=942-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://emedicine.medscape.com/article/277621-diagnosis">http://emedicine.medscape.com/article/277621-diagnosis</a></span></li>
<li id="cite_note-pmid14601099-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid14601099_27-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Peuchmaur M, d'Amore ES, Joshi VV, Hata J, Roald B, Dehner LP, Gerbing RB, Stram DO, Lukens JN, Matthay KK, Shimada H (2003). "Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular". <i>Cancer</i> <b>98</b> (10): 2274–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fcncr.11773">10.1002/cncr.11773</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14601099">14601099</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Revision+of+the+International+Neuroblastoma+Pathology+Classification%3A+confirmation+of+favorable+and+unfavorable+prognostic+subsets+in+ganglioneuroblastoma%2C+nodular&amp;rft.aulast=Peuchmaur+M%2C+d%27Amore+ES%2C+Joshi+VV%2C+Hata+J%2C+Roald+B%2C+Dehner+LP%2C+Gerbing+RB%2C+Stram+DO%2C+Lukens+JN%2C+Matthay+KK%2C+Shimada+H&amp;rft.au=Peuchmaur+M%2C+d%27Amore+ES%2C+Joshi+VV%2C+Hata+J%2C+Roald+B%2C+Dehner+LP%2C+Gerbing+RB%2C+Stram+DO%2C+Lukens+JN%2C+Matthay+KK%2C+Shimada+H&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.11773&amp;rft_id=info%3Apmid%2F14601099&amp;rft.issue=10&amp;rft.jtitle=Cancer&amp;rft.pages=2274-81&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=98" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleNeuroblastoma_Treatment_-_National_Cancer_Institute-28"><span class="mw-cite-backlink">^ <a href="#cite_ref-titleNeuroblastoma_Treatment_-_National_Cancer_Institute_28-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-titleNeuroblastoma_Treatment_-_National_Cancer_Institute_28-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/pdq/treatment/neuroblastoma/HealthProfessional/page3#Section_185">"Neuroblastoma Treatment - National Cancer Institute"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-07-30</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Neuroblastoma+Treatment+-+National+Cancer+Institute&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fpdq%2Ftreatment%2Fneuroblastoma%2FHealthProfessional%2Fpage3%23Section_185&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid3199170-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid3199170_29-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI (1988). <a rel="nofollow" class="external text" href="http://www.jco.org/cgi/pmidlookup?view=long&amp;pmid=3199170">"International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma"</a>. <i>J. Clin. Oncol.</i> <b>6</b> (12): 1874–81. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3199170">3199170</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=International+criteria+for+diagnosis%2C+staging%2C+and+response+to+treatment+in+patients+with+neuroblastoma&amp;rft.au=Brodeur+GM%2C+Seeger+RC%2C+Barrett+A%2C+Berthold+F%2C+Castleberry+RP%2C+D%27Angio+G%2C+De+Bernardi+B%2C+Evans+AE%2C+Favrot+M%2C+Freeman+AI&amp;rft.aulast=Brodeur+GM%2C+Seeger+RC%2C+Barrett+A%2C+Berthold+F%2C+Castleberry+RP%2C+D%27Angio+G%2C+De+Bernardi+B%2C+Evans+AE%2C+Favrot+M%2C+Freeman+AI&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.jco.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D3199170&amp;rft_id=info%3Apmid%2F3199170&amp;rft.issue=12&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.pages=1874-81&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid8336186-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8336186_30-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F (1993). <a rel="nofollow" class="external text" href="http://www.jco.org/cgi/pmidlookup?view=long&amp;pmid=8336186">"Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment"</a>. <i>J. Clin. Oncol.</i> <b>11</b> (8): 1466–77. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8336186">8336186</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Revisions+of+the+international+criteria+for+neuroblastoma+diagnosis%2C+staging%2C+and+response+to+treatment&amp;rft.au=Brodeur+GM%2C+Pritchard+J%2C+Berthold+F%2C+Carlsen+NL%2C+Castel+V%2C+Castelberry+RP%2C+De+Bernardi+B%2C+Evans+AE%2C+Favrot+M%2C+Hedborg+F&amp;rft.aulast=Brodeur+GM%2C+Pritchard+J%2C+Berthold+F%2C+Carlsen+NL%2C+Castel+V%2C+Castelberry+RP%2C+De+Bernardi+B%2C+Evans+AE%2C+Favrot+M%2C+Hedborg+F&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.jco.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D8336186&amp;rft_id=info%3Apmid%2F8336186&amp;rft.issue=8&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.pages=1466-77&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16116154-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16116154_31-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O'Leary M, Gerbing RB, Matthay KK (2005). <a rel="nofollow" class="external text" href="http://jco.ascopubs.org/cgi/content/full/23/27/6474">"Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study"</a>. <i>J Clin Oncol</i> <b>23</b> (27): 6474–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2005.05.183">10.1200/JCO.2005.05.183</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16116154">16116154</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Favorable+prognosis+for+patients+12+to+18+months+of+age+with+stage+4+nonamplified+MYCN+neuroblastoma%3A+a+Children%27s+Cancer+Group+Study&amp;rft.aulast=Schmidt+ML%2C+Lal+A%2C+Seeger+RC%2C+Maris+JM%2C+Shimada+H%2C+O%27Leary+M%2C+Gerbing+RB%2C+Matthay+KK&amp;rft.au=Schmidt+ML%2C+Lal+A%2C+Seeger+RC%2C+Maris+JM%2C+Shimada+H%2C+O%27Leary+M%2C+Gerbing+RB%2C+Matthay+KK&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjco.ascopubs.org%2Fcgi%2Fcontent%2Ffull%2F23%2F27%2F6474&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2005.05.183&amp;rft_id=info%3Apmid%2F16116154&amp;rft.issue=27&amp;rft.jtitle=J+Clin+Oncol&amp;rft.pages=6474-80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17586306-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17586306_32-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(07)60983-0">"Neuroblastoma"</a>. <i>Lancet</i> <b>369</b> (9579): 2106–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2807%2960983-0">10.1016/S0140-6736(07)60983-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17586306">17586306</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Neuroblastoma&amp;rft.aulast=Maris+JM%2C+Hogarty+MD%2C+Bagatell+R%2C+Cohn+SL&amp;rft.au=Maris+JM%2C+Hogarty+MD%2C+Bagatell+R%2C+Cohn+SL&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0140-6736%2807%2960983-0&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2807%2960983-0&amp;rft_id=info%3Apmid%2F17586306&amp;rft.issue=9579&amp;rft.jtitle=Lancet&amp;rft.pages=2106-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=369" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid_33-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Cohn SL, London WB, Monclair T, Matthay KK, Ambros PF, Pearson AD, for the INRG Working Group (2007). <a rel="nofollow" class="external text" href="http://www.asco.org/ASCO/Abstracts+&amp;+Virtual+Meeting/Abstracts?&amp;vmview=abst_detail_view&amp;confID=47&amp;abstractID=30945">"Update on the development of the international neuroblastoma risk group (INRG) classification schema"</a> <span style="font-size:85%;">(ABSTRACT)</span>. <i>Journal of Clinical Oncology 2007 ASCO Annual Meeting Proceedings Part 1</i> <b>25</b> (18S).</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Update+on+the+development+of+the+international+neuroblastoma+risk+group+%28INRG%29+classification+schema&amp;rft.au=Cohn+SL%2C+London+WB%2C+Monclair+T%2C+Matthay+KK%2C+Ambros+PF%2C+Pearson+AD%2C+for+the+INRG+Working+Group&amp;rft.aulast=Cohn+SL%2C+London+WB%2C+Monclair+T%2C+Matthay+KK%2C+Ambros+PF%2C+Pearson+AD%2C+for+the+INRG+Working+Group&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.asco.org%2FASCO%2FAbstracts%2B%26%2BVirtual%2BMeeting%2FAbstracts%3F%26vmview%3Dabst_detail_view%26confID%3D47%26abstractID%3D30945&amp;rft.issue=18S&amp;rft.jtitle=Journal+of+Clinical+Oncology+2007+ASCO+Annual+Meeting+Proceedings+Part+1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11932470-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11932470_34-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Woods WG, Gao RN, Shuster JJ, Robison LL, Bernstein M, Weitzman S, Bunin G, Levy I, Brossard J, Dougherty G, Tuchman M, Lemieux B (2002). <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=11932470&amp;promo=ONFLNS19">"Screening of infants and mortality due to neuroblastoma"</a>. <i>N. Engl. J. Med.</i> <b>346</b> (14): 1041–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa012387">10.1056/NEJMoa012387</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11932470">11932470</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Screening+of+infants+and+mortality+due+to+neuroblastoma&amp;rft.aulast=Woods+WG%2C+Gao+RN%2C+Shuster+JJ%2C+Robison+LL%2C+Bernstein+M%2C+Weitzman+S%2C+Bunin+G%2C+Levy+I%2C+Brossard+J%2C+Dougherty+G%2C+Tuchman+M%2C+Lemieux+B&amp;rft.au=Woods+WG%2C+Gao+RN%2C+Shuster+JJ%2C+Robison+LL%2C+Bernstein+M%2C+Weitzman+S%2C+Bunin+G%2C+Levy+I%2C+Brossard+J%2C+Dougherty+G%2C+Tuchman+M%2C+Lemieux+B&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fpmidlookup%3Fview%3Dshort%26pmid%3D11932470%26promo%3DONFLNS19&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa012387&amp;rft_id=info%3Apmid%2F11932470&amp;rft.issue=14&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1041-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=346" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12880955-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12880955_35-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Schilling FH, Spix C, Berthold F, Erttmann R, Sander J, Treuner J, Michaelis J (2003). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S0304383503000776">"Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany"</a>. <i>Cancer Lett.</i> <b>197</b> (1-2): 19–28. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0304-3835%2803%2900077-6">10.1016/S0304-3835(03)00077-6</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12880955">12880955</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Children+may+not+benefit+from+neuroblastoma+screening+at+1+year+of+age.+Updated+results+of+the+population+based+controlled+trial+in+Germany&amp;rft.aulast=Schilling+FH%2C+Spix+C%2C+Berthold+F%2C+Erttmann+R%2C+Sander+J%2C+Treuner+J%2C+Michaelis+J&amp;rft.au=Schilling+FH%2C+Spix+C%2C+Berthold+F%2C+Erttmann+R%2C+Sander+J%2C+Treuner+J%2C+Michaelis+J&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0304383503000776&amp;rft_id=info%3Adoi%2F10.1016%2FS0304-3835%2803%2900077-6&amp;rft_id=info%3Apmid%2F12880955&amp;rft.issue=1-2&amp;rft.jtitle=Cancer+Lett.&amp;rft.pages=19-28&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=197" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15128908-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15128908_36-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Tsubono Y, Hisamichi S (2004). "A halt to neuroblastoma screening in Japan". <i>N. Engl. J. Med.</i> <b>350</b> (19): 2010–1. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM200405063501922">10.1056/NEJM200405063501922</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15128908">15128908</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=A+halt+to+neuroblastoma+screening+in+Japan&amp;rft.aulast=Tsubono+Y%2C+Hisamichi+S&amp;rft.au=Tsubono+Y%2C+Hisamichi+S&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM200405063501922&amp;rft_id=info%3Apmid%2F15128908&amp;rft.issue=19&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=2010-1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=350" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleNeuroblastoma_Screening_-_National_Cancer_Institute-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleNeuroblastoma_Screening_-_National_Cancer_Institute_37-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/pdq/screening/neuroblastoma/HealthProfessional/page3">"Neuroblastoma Screening - National Cancer Institute"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-07-30</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Neuroblastoma+Screening+-+National+Cancer+Institute&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fpdq%2Fscreening%2Fneuroblastoma%2FHealthProfessional%2Fpage3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text">Darshak Sanghavi, <a rel="nofollow" class="external text" href="http://www.slate.com/id/2154563/">"Screen Alert: How an Ounce of RX Prevention can Cause a Pound of Hurt"</a>, <i>Slate</i> magazine, November 28, 2006</span></li>
<li id="cite_note-pmid18081947-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18081947_39-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Johnson E, Dean SM, Sondel PM (2007). <a rel="nofollow" class="external text" href="http://journals.cambridge.org/abstract_S1462399407000518">"Antibody-based immunotherapy in high-risk neuroblastoma"</a> <span style="font-size:85%;">(ABSTRACT)</span>. <i><a href="/w/index.php?title=Expert_Rev_Mol_Med&amp;action=edit&amp;redlink=1" class="new" title="Expert Rev Mol Med (page does not exist)">Expert Rev Mol Med</a></i> <b>9</b> (34): 1–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1017%2FS1462399407000518">10.1017/S1462399407000518</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18081947">18081947</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Antibody-based+immunotherapy+in+high-risk+neuroblastoma&amp;rft.au=Johnson+E%2C+Dean+SM%2C+Sondel+PM&amp;rft.aulast=Johnson+E%2C+Dean+SM%2C+Sondel+PM&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjournals.cambridge.org%2Fabstract_S1462399407000518&amp;rft_id=info%3Adoi%2F10.1017%2FS1462399407000518&amp;rft_id=info%3Apmid%2F18081947&amp;rft.issue=34&amp;rft.jtitle=Expert+Rev+Mol+Med&amp;rft.pages=1-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><span class="citation journal">Brodeur GM (March 2003). "Neuroblastoma: biological insights into a clinical enigma". <i>Nat. Rev. Cancer</i> <b>3</b> (3): 203–16. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnrc1014">10.1038/nrc1014</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12612655">12612655</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Neuroblastoma%3A+biological+insights+into+a+clinical+enigma&amp;rft.au=Brodeur+GM&amp;rft.aulast=Brodeur+GM&amp;rft.date=March+2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc1014&amp;rft_id=info%3Apmid%2F12612655&amp;rft.issue=3&amp;rft.jtitle=Nat.+Rev.+Cancer&amp;rft.pages=203-16&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17943719-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17943719_41-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Schulte JH, Horn S, Otto T, Samans B, Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L, Buettner R, Schramm A, Christiansen H, Eilers M, Eggert A, Berwanger B (2008). "MYCN regulates oncogenic MicroRNAs in neuroblastoma". <i>Int. J. Cancer</i> <b>122</b> (3): 699–704. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fijc.23153">10.1002/ijc.23153</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17943719">17943719</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=MYCN+regulates+oncogenic+MicroRNAs+in+neuroblastoma&amp;rft.aulast=Schulte+JH%2C+Horn+S%2C+Otto+T%2C+Samans+B%2C+Heukamp+LC%2C+Eilers+UC%2C+Krause+M%2C+Astrahantseff+K%2C+Klein-Hitpass+L%2C+Buettner+R%2C+Schramm+A%2C+Christiansen+H%2C+Eilers+M%2C+Eggert+A%2C+Berwanger+B&amp;rft.au=Schulte+JH%2C+Horn+S%2C+Otto+T%2C+Samans+B%2C+Heukamp+LC%2C+Eilers+UC%2C+Krause+M%2C+Astrahantseff+K%2C+Klein-Hitpass+L%2C+Buettner+R%2C+Schramm+A%2C+Christiansen+H%2C+Eilers+M%2C+Eggert+A%2C+Berwanger+B&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.23153&amp;rft_id=info%3Apmid%2F17943719&amp;rft.issue=3&amp;rft.jtitle=Int.+J.+Cancer&amp;rft.pages=699-704&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=122" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleTranslating_Neuroblastoma_Genomics_to_the_Clinic_-_J._Maris_presentation_ASCO_2007-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleTranslating_Neuroblastoma_Genomics_to_the_Clinic_-_J._Maris_presentation_ASCO_2007_42-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://media.asco.org/player/default.aspx?LectureID=317&amp;conferenceFolder=vm2007&amp;SessionFolder=01028&amp;slideonly=yes&amp;TrackID=N929&amp;LectureTitle=Translating%20Neuroblastoma%20Genomics%20to%20the%20Clinic&amp;Key=vm_47_10_222_317&amp;SpeakerName=%3b%20Chair%3a%20John%20M.%20Maris%2c%20MD&amp;mediaURL=%2fmedia&amp;ServerName=media.asco.org&amp;max=28&amp;ext=jpg&amp;useASX=false&amp;playtype=&amp;playtype=&amp;playtype=,">"Translating Neuroblastoma Genomics to the Clinic - J. Maris presentation ASCO 2007"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-01-13</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Translating+Neuroblastoma+Genomics+to+the+Clinic+-+J.+Maris+presentation+ASCO+2007&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fmedia.asco.org%2Fplayer%2Fdefault.aspx%3FLectureID%3D317%26conferenceFolder%3Dvm2007%26SessionFolder%3D01028%26slideonly%3Dyes%26TrackID%3DN929%26LectureTitle%3DTranslating%2520Neuroblastoma%2520Genomics%2520to%2520the%2520Clinic%26Key%3Dvm_47_10_222_317%26SpeakerName%3D%253b%2520Chair%253a%2520John%2520M.%2520Maris%252c%2520MD%26mediaURL%3D%252fmedia%26ServerName%3Dmedia.asco.org%26max%3D28%26ext%3Djpg%26useASX%3Dfalse%26playtype%3D%26playtype%3D%26playtype%3D%2C&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17897457-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17897457_43-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Gisselsson D, Lundberg G, Ora I, Höglund M (2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2042979">"Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas"</a>. <i>J Carcinog</i> <b>6</b>: 15. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1477-3163-6-15">10.1186/1477-3163-6-15</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2042979">2042979</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17897457">17897457</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Distinct+evolutionary+mechanisms+for+genomic+imbalances+in+high-risk+and+low-risk+neuroblastomas&amp;rft.au=Gisselsson+D%2C+Lundberg+G%2C+Ora+I%2C+H%C3%B6glund+M&amp;rft.aulast=Gisselsson+D%2C+Lundberg+G%2C+Ora+I%2C+H%C3%B6glund+M&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2042979&amp;rft_id=info%3Adoi%2F10.1186%2F1477-3163-6-15&amp;rft_id=info%3Apmc%2F2042979&amp;rft_id=info%3Apmid%2F17897457&amp;rft.jtitle=J+Carcinog&amp;rft.pages=15&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9988866-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9988866_44-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Haase GM, Perez C, Atkinson JB (1999). "Current aspects of biology, risk assessment, and treatment of neuroblastoma". <i>Semin Surg Oncol</i> <b>16</b> (2): 91–104. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F%28SICI%291098-2388%28199903%2916%3A2%3C91%3A%3AAID-SSU3%3E3.0.CO%3B2-1">10.1002/(SICI)1098-2388(199903)16:2&lt;91::AID-SSU3&gt;3.0.CO;2-1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9988866">9988866</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Current+aspects+of+biology%2C+risk+assessment%2C+and+treatment+of+neuroblastoma&amp;rft.au=Haase+GM%2C+Perez+C%2C+Atkinson+JB&amp;rft.aulast=Haase+GM%2C+Perez+C%2C+Atkinson+JB&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291098-2388%28199903%2916%3A2%3C91%3A%3AAID-SSU3%3E3.0.CO%3B2-1&amp;rft_id=info%3Apmid%2F9988866&amp;rft.issue=2&amp;rft.jtitle=Semin+Surg+Oncol&amp;rft.pages=91-104&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18037943-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18037943_45-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Fish JD, Grupp SA (2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2892221">"Stem cell transplantation for neuroblastoma"</a>. <i>Bone Marrow Transplant</i> <b>41</b> (2): 159–65. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.bmt.1705929">10.1038/sj.bmt.1705929</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2892221">2892221</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18037943">18037943</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Stem+cell+transplantation+for+neuroblastoma&amp;rft.au=Fish+JD%2C+Grupp+SA&amp;rft.aulast=Fish+JD%2C+Grupp+SA&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2892221&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.bmt.1705929&amp;rft_id=info%3Apmc%2F2892221&amp;rft_id=info%3Apmid%2F18037943&amp;rft.issue=2&amp;rft.jtitle=Bone+Marrow+Transplant&amp;rft.pages=159-65&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=41" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10519894-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10519894_46-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP (1999). <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=10519894&amp;promo=ONFLNS19">"Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group"</a>. <i>N. Engl. J. Med.</i> <b>341</b> (16): 1165–73. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM199910143411601">10.1056/NEJM199910143411601</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10519894">10519894</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Treatment+of+high-risk+neuroblastoma+with+intensive+chemotherapy%2C+radiotherapy%2C+autologous+bone+marrow+transplantation%2C+and+13-cis-retinoic+acid.+Children%27s+Cancer+Group&amp;rft.aulast=Matthay+KK%2C+Villablanca+JG%2C+Seeger+RC%2C+Stram+DO%2C+Harris+RE%2C+Ramsay+NK%2C+Swift+P%2C+Shimada+H%2C+Black+CT%2C+Brodeur+GM%2C+Gerbing+RB%2C+Reynolds+CP&amp;rft.au=Matthay+KK%2C+Villablanca+JG%2C+Seeger+RC%2C+Stram+DO%2C+Harris+RE%2C+Ramsay+NK%2C+Swift+P%2C+Shimada+H%2C+Black+CT%2C+Brodeur+GM%2C+Gerbing+RB%2C+Reynolds+CP&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fpmidlookup%3Fview%3Dshort%26pmid%3D10519894%26promo%3DONFLNS19&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199910143411601&amp;rft_id=info%3Apmid%2F10519894&amp;rft.issue=16&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1165-73&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=341" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20879881-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20879881_47-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM (September 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3086629">"Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma"</a>. <i><a href="/wiki/N._Engl._J._Med." title="N. Engl. J. Med." class="mw-redirect">N. Engl. J. Med.</a></i> <b>363</b> (14): 1324–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa0911123">10.1056/NEJMoa0911123</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3086629">3086629</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20879881">20879881</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Anti-GD2+antibody+with+GM-CSF%2C+interleukin-2%2C+and+isotretinoin+for+neuroblastoma&amp;rft.aulast=Yu+AL%2C+Gilman+AL%2C+Ozkaynak+MF%2C+London+WB%2C+Kreissman+SG%2C+Chen+HX%2C+Smith+M%2C+Anderson+B%2C+Villablanca+JG%2C+Matthay+KK%2C+Shimada+H%2C+Grupp+SA%2C+Seeger+R%2C+Reynolds+CP%2C+Buxton+A%2C+Reisfeld+RA%2C+Gillies+SD%2C+Cohn+SL%2C+Maris+JM%2C+Sondel+PM&amp;rft.au=Yu+AL%2C+Gilman+AL%2C+Ozkaynak+MF%2C+London+WB%2C+Kreissman+SG%2C+Chen+HX%2C+Smith+M%2C+Anderson+B%2C+Villablanca+JG%2C+Matthay+KK%2C+Shimada+H%2C+Grupp+SA%2C+Seeger+R%2C+Reynolds+CP%2C+Buxton+A%2C+Reisfeld+RA%2C+Gillies+SD%2C+Cohn+SL%2C+Maris+JM%2C+Sondel+PM&amp;rft.date=September+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3086629&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa0911123&amp;rft_id=info%3Apmc%2F3086629&amp;rft_id=info%3Apmid%2F20879881&amp;rft.issue=14&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1324-34&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=363" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleNeuroblastoma_Treatment_-_National_Cancer_Institute_.282.29-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleNeuroblastoma_Treatment_-_National_Cancer_Institute_.282.29_48-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/pdq/treatment/neuroblastoma/HealthProfessional/page3#Section_17">"Neuroblastoma Treatment - National Cancer Institute"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-07-30</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Neuroblastoma+Treatment+-+National+Cancer+Institute&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fpdq%2Ftreatment%2Fneuroblastoma%2FHealthProfessional%2Fpage3%23Section_17&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlA_phase_III_randomized_trial_of_the_chimeric_anti-GD2_antibody_ch14.18_with_GM-CSF_and_IL2_as_immunotherapy_following_dose_intensive_chemotherapy_for_high-risk_neuroblastoma:_Children.27s_Oncology_Group_.28COG.29_study_ANBL0032-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlA_phase_III_randomized_trial_of_the_chimeric_anti-GD2_antibody_ch14.18_with_GM-CSF_and_IL2_as_immunotherapy_following_dose_intensive_chemotherapy_for_high-risk_neuroblastoma:_Children.27s_Oncology_Group_.28COG.29_study_ANBL0032_49-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.abstract.asco.org/AbstView_65_35748.html">"A phase III randomized trial of the chimeric anti-GD2 antibody ch14.18 with GM-CSF and IL2 as immunotherapy following dose intensive chemotherapy for high-risk neuroblastoma: Children's Oncology Group (COG) study ANBL0032"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=A+phase+III+randomized+trial+of+the+chimeric+anti-GD2+antibody+ch14.18+with+GM-CSF+and+IL2+as+immunotherapy+following+dose+intensive+chemotherapy+for+high-risk+neuroblastoma%3A+Children%27s+Oncology+Group+%28COG%29+study+ANBL0032&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.abstract.asco.org%2FAbstView_65_35748.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlReduction_From_Seven_to_Five_Cycles_of_Intensive_Induction_Chemotherapy_in_Children_With_High-Risk_Neuroblastoma_--_Kushner_et_al._22_.2824.29:_4888_--_Journal_of_Clinical_Oncology-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlReduction_From_Seven_to_Five_Cycles_of_Intensive_Induction_Chemotherapy_in_Children_With_High-Risk_Neuroblastoma_--_Kushner_et_al._22_.2824.29:_4888_--_Journal_of_Clinical_Oncology_50-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://jco.ascopubs.org/cgi/content/full/22/24/4888">"Reduction From Seven to Five Cycles of Intensive Induction Chemotherapy in Children With High-Risk Neuroblastoma -- Kushner et al. 22 (24): 4888 -- Journal of Clinical Oncology"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Reduction+From+Seven+to+Five+Cycles+of+Intensive+Induction+Chemotherapy+in+Children+With+High-Risk+Neuroblastoma+--+Kushner+et+al.+22+%2824%29%3A+4888+--+Journal+of+Clinical+Oncology&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fjco.ascopubs.org%2Fcgi%2Fcontent%2Ffull%2F22%2F24%2F4888&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleResponse_and_toxicity_to_a_dose-intensive_multi-agent_chemotherapy_induction_regimen_for_high_risk_neuroblastoma_.28HR-NB.29:_A_Childrens_Oncology_Group_.28COG_A3973.29_study._-_ASCO-51"><span class="mw-cite-backlink">^ <a href="#cite_ref-titleResponse_and_toxicity_to_a_dose-intensive_multi-agent_chemotherapy_induction_regimen_for_high_risk_neuroblastoma_.28HR-NB.29:_A_Childrens_Oncology_Group_.28COG_A3973.29_study._-_ASCO_51-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-titleResponse_and_toxicity_to_a_dose-intensive_multi-agent_chemotherapy_induction_regimen_for_high_risk_neuroblastoma_.28HR-NB.29:_A_Childrens_Oncology_Group_.28COG_A3973.29_study._-_ASCO_51-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&amp;vmview=abst_detail_view&amp;confID=47&amp;abstractID=31659">"Response and toxicity to a dose-intensive multi-agent chemotherapy induction regimen for high risk neuroblastoma (HR-NB): A Children's Oncology Group (COG A3973) study. - ASCO"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-02-02</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Response+and+toxicity+to+a+dose-intensive+multi-agent+chemotherapy+induction+regimen+for+high+risk+neuroblastoma+%28HR-NB%29%3A+A+Children%27s+Oncology+Group+%28COG+A3973%29+study.+-+ASCO&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.asco.org%2FASCO%2FAbstracts%2B%2526%2BVirtual%2BMeeting%2FAbstracts%3F%26vmview%3Dabst_detail_view%26confID%3D47%26abstractID%3D31659&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16395684-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16395684_52-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ceschel S, Casotto V, Valsecchi MG, Tamaro P, Jankovic M, Hanau G, Fossati F, Pillon M, Rondelli R, Sandri A, Silvestri D, Haupt R, Cuttini M (Oct 2006). "Survival after relapse in children with solid tumors: a follow-up study from the Italian off-therapy registry". <i>Pediatr Blood Cancer</i> <b>47</b> (5): 560–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fpbc.20726">10.1002/pbc.20726</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16395684">16395684</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Survival+after+relapse+in+children+with+solid+tumors%3A+a+follow-up+study+from+the+Italian+off-therapy+registry&amp;rft.au=Ceschel+S%2C+Casotto+V%2C+Valsecchi+MG%2C+Tamaro+P%2C+Jankovic+M%2C+Hanau+G%2C+Fossati+F%2C+Pillon+M%2C+Rondelli+R%2C+Sandri+A%2C+Silvestri+D%2C+Haupt+R%2C+Cuttini+M&amp;rft.aulast=Ceschel+S%2C+Casotto+V%2C+Valsecchi+MG%2C+Tamaro+P%2C+Jankovic+M%2C+Hanau+G%2C+Fossati+F%2C+Pillon+M%2C+Rondelli+R%2C+Sandri+A%2C+Silvestri+D%2C+Haupt+R%2C+Cuttini+M&amp;rft.date=Oct+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fpbc.20726&amp;rft_id=info%3Apmid%2F16395684&amp;rft.issue=5&amp;rft.jtitle=Pediatr+Blood+Cancer&amp;rft.pages=560-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=47" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17974716-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17974716_53-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Gurney JG, Tersak JM, Ness KK, Landier W, Matthay KK, Schmidt ML (2007). "Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group". <i>Pediatrics</i> <b>120</b> (5): e1229–36. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1542%2Fpeds.2007-0178">10.1542/peds.2007-0178</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17974716">17974716</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Hearing+loss%2C+quality+of+life%2C+and+academic+problems+in+long-term+neuroblastoma+survivors%3A+a+report+from+the+Children%27s+Oncology+Group&amp;rft.au=Gurney+JG%2C+Tersak+JM%2C+Ness+KK%2C+Landier+W%2C+Matthay+KK%2C+Schmidt+ML&amp;rft.aulast=Gurney+JG%2C+Tersak+JM%2C+Ness+KK%2C+Landier+W%2C+Matthay+KK%2C+Schmidt+ML&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1542%2Fpeds.2007-0178&amp;rft_id=info%3Apmid%2F17974716&amp;rft.issue=5&amp;rft.jtitle=Pediatrics&amp;rft.pages=e1229-36&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=120" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17724446-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17724446_54-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Trahair TN, Vowels MR, Johnston K, Cohn RJ, Russell SJ, Neville KA, Carroll S, Marshall GM (2007). "Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation". <i>Bone Marrow Transplant</i> <b>40</b> (8): 741–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.bmt.1705809">10.1038/sj.bmt.1705809</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17724446">17724446</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Long-term+outcomes+in+children+with+high-risk+neuroblastoma+treated+with+autologous+stem+cell+transplantation&amp;rft.aulast=Trahair+TN%2C+Vowels+MR%2C+Johnston+K%2C+Cohn+RJ%2C+Russell+SJ%2C+Neville+KA%2C+Carroll+S%2C+Marshall+GM&amp;rft.au=Trahair+TN%2C+Vowels+MR%2C+Johnston+K%2C+Cohn+RJ%2C+Russell+SJ%2C+Neville+KA%2C+Carroll+S%2C+Marshall+GM&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.bmt.1705809&amp;rft_id=info%3Apmid%2F17724446&amp;rft.issue=8&amp;rft.jtitle=Bone+Marrow+Transplant&amp;rft.pages=741-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=40" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.ajc.com/health/content/shared-auto/healthnews/-bon/602068.html">"Childhood Cancer Survivors Face Increased Sarcoma Risk"</a>, <a href="/w/index.php?title=HealthDay&amp;action=edit&amp;redlink=1" class="new" title="HealthDay (page does not exist)">HealthDay</a> News, February 21, 2007</span></li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text">Oeffinger et al., <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/content/abstract/355/15/1572">"Chronic Health Conditions in Adult Survivors of Childhood Cancer"</a>, New England Journal of Medicine, October 12, 2006</span></li>
<li id="cite_note-urlLong-term_Outcomes_in_Survivors_of_Neuroblastoma:_A_Report_From_the_Childhood_Cancer_Survivor_Study_--_Laverdi.C3.A8re_et_al..2C_10.1093.2Fjnci.2Fdjp230_--_JNCI_Journal_of_the_National_Cancer_Institute-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlLong-term_Outcomes_in_Survivors_of_Neuroblastoma:_A_Report_From_the_Childhood_Cancer_Survivor_Study_--_Laverdi.C3.A8re_et_al..2C_10.1093.2Fjnci.2Fdjp230_--_JNCI_Journal_of_the_National_Cancer_Institute_57-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://jnci.oxfordjournals.org/cgi/content/abstract/djp230">"Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor Study -- Laverdière et al., 10.1093/jnci/djp230 -- JNCI Journal of the National Cancer Institute"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Long-term+Outcomes+in+Survivors+of+Neuroblastoma%3A+A+Report+From+the+Childhood+Cancer+Survivor+Study+--+Laverdi%C3%A8re+et+al.%2C+10.1093%2Fjnci%2Fdjp230+--+JNCI+Journal+of+the+National+Cancer+Institute&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fjnci.oxfordjournals.org%2Fcgi%2Fcontent%2Fabstract%2Fdjp230&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19171713-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19171713_58-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Janoueix-Lerosey I, Schleiermacher G, Michels E, Mosseri V, Ribeiro A, Lequin D, Vermeulen J, Couturier J, Peuchmaur M, Valent A, Plantaz D, Rubie H, Valteau-Couanet D, Thomas C, Combaret V, Rousseau R, Eggert A, Michon J, Speleman F, Delattre O (March 2009). <a rel="nofollow" class="external text" href="http://www.jco.org/cgi/pmidlookup?view=long&amp;pmid=19171713">"Overall genomic pattern is a predictor of outcome in neuroblastoma"</a>. <i>J. Clin. Oncol.</i> <b>27</b> (7): 1026–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2008.16.0630">10.1200/JCO.2008.16.0630</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19171713">19171713</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Overall+genomic+pattern+is+a+predictor+of+outcome+in+neuroblastoma&amp;rft.au=Janoueix-Lerosey+I%2C+Schleiermacher+G%2C+Michels+E%2C+Mosseri+V%2C+Ribeiro+A%2C+Lequin+D%2C+Vermeulen+J%2C+Couturier+J%2C+Peuchmaur+M%2C+Valent+A%2C+Plantaz+D%2C+Rubie+H%2C+Valteau-Couanet+D%2C+Thomas+C%2C+Combaret+V%2C+Rousseau+R%2C+Eggert+A%2C+Michon+J%2C+Speleman+F%2C+Delattre+O&amp;rft.aulast=Janoueix-Lerosey+I%2C+Schleiermacher+G%2C+Michels+E%2C+Mosseri+V%2C+Ribeiro+A%2C+Lequin+D%2C+Vermeulen+J%2C+Couturier+J%2C+Peuchmaur+M%2C+Valent+A%2C+Plantaz+D%2C+Rubie+H%2C+Valteau-Couanet+D%2C+Thomas+C%2C+Combaret+V%2C+Rousseau+R%2C+Eggert+A%2C+Michon+J%2C+Speleman+F%2C+Delattre+O&amp;rft.date=March+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.jco.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D19171713&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2008.16.0630&amp;rft_id=info%3Apmid%2F19171713&amp;rft.issue=7&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.pages=1026-33&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><span class="citation journal">Vandesompele J, Baudis M, Preter K De, Roy N Van, Ambros P, Bown N, Brinkschmidt C, Christiansen H, Combaret V et al. (2005). "Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma". <i>J Clin Oncol</i> <b>10</b> (23): 2280–2299.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Unequivocal+delineation+of+clinicogenetic+subgroups+and+development+of+a+new+model+for+improved+outcome+prediction+in+neuroblastoma&amp;rft.aulast=Vandesompele+J%2C+Baudis+M%2C+Preter+K+De%2C+Roy+N+Van%2C+Ambros+P%2C+Bown+N%2C+Brinkschmidt+C%2C+Christiansen+H%2C+Combaret+V&amp;rft.au=Vandesompele+J%2C+Baudis+M%2C+Preter+K+De%2C+Roy+N+Van%2C+Ambros+P%2C+Bown+N%2C+Brinkschmidt+C%2C+Christiansen+H%2C+Combaret+V&amp;rft.date=2005&amp;rft.genre=article&amp;rft.issue=23&amp;rft.jtitle=J+Clin+Oncol&amp;rft.pages=2280-2299&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text">Michels, E; Vandesompele, J; Hoebeeck, J; Menten, B; De Preter, K; Laureys, G; Van Roy, N; Speleman, F. Genome wide measurement of DNA copy number changes in neuroblastoma: dissecting amplicons and mapping losses, gains and breakpoints. Cytogenet Genome Res. 2006;115:273–282. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1159%2F000095924">10.1159/000095924</a>. [PubMed]</span></li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text">Carén H, Erichsen J, Olsson L, Enerbäck C, Sjöberg RM, Abrahamsson J, Kogner P, Martinsson T. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene. BMC Genomics. 2008 Jul 29;9:353.</span></li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text">Brodeur GM, Castleberry RP. Neuroblastoma. In: Pizzo PA, Poplack DG. Principles and practice of pediatric oncology, 3rd ed. 1997:761-797.</span></li>
<li id="cite_note-pmid9149032-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9149032_63-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Franks LM, Bollen A, Seeger RC, Stram DO, Matthay KK (1997). "Neuroblastoma in adults and adolescents: an indolent course with poor survival". <i>Cancer</i> <b>79</b> (10): 2028–35. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F%28SICI%291097-0142%2819970515%2979%3A10%3C2028%3A%3AAID-CNCR26%3E3.0.CO%3B2-V">10.1002/(SICI)1097-0142(19970515)79:10&lt;2028::AID-CNCR26&gt;3.0.CO;2-V</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9149032">9149032</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Neuroblastoma+in+adults+and+adolescents%3A+an+indolent+course+with+poor+survival&amp;rft.au=Franks+LM%2C+Bollen+A%2C+Seeger+RC%2C+Stram+DO%2C+Matthay+KK&amp;rft.aulast=Franks+LM%2C+Bollen+A%2C+Seeger+RC%2C+Stram+DO%2C+Matthay+KK&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291097-0142%2819970515%2979%3A10%3C2028%3A%3AAID-CNCR26%3E3.0.CO%3B2-V&amp;rft_id=info%3Apmid%2F9149032&amp;rft.issue=10&amp;rft.jtitle=Cancer&amp;rft.pages=2028-35&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=79" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18545256-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18545256_64-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ladenstein R, Pötschger U, Hartman O, Pearson AD, Klingebiel T, Castel V, Yaniv I, Demirer T, Dini G (June 2008). "28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures". <i>Bone Marrow Transplant</i>. 41 Suppl 2: S118–27. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fbmt.2008.69">10.1038/bmt.2008.69</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18545256">18545256</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=28+years+of+high-dose+therapy+and+SCT+for+neuroblastoma+in+Europe%3A+lessons+from+more+than+4000+procedures&amp;rft.au=Ladenstein+R%2C+P%C3%B6tschger+U%2C+Hartman+O%2C+Pearson+AD%2C+Klingebiel+T%2C+Castel+V%2C+Yaniv+I%2C+Demirer+T%2C+Dini+G&amp;rft.aulast=Ladenstein+R%2C+P%C3%B6tschger+U%2C+Hartman+O%2C+Pearson+AD%2C+Klingebiel+T%2C+Castel+V%2C+Yaniv+I%2C+Demirer+T%2C+Dini+G&amp;rft.date=June+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fbmt.2008.69&amp;rft_id=info%3Apmid%2F18545256&amp;rft.jtitle=Bone+Marrow+Transplant.&amp;rft.pages=S118-27&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=41+Suppl+2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><span class="citation book">Cheung, Nai-Kong (2005). <i>Neuroblastoma</i>. p. 63. <a href="/wiki/Springer-Verlag" title="Springer-Verlag" class="mw-redirect">Springer-Verlag</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/3-540-40841-X" title="Special:BookSources/3-540-40841-X">3-540-40841-X</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.au=Cheung%2C+Nai-Kong&amp;rft.aufirst=Nai-Kong&amp;rft.aulast=Cheung&amp;rft.btitle=Neuroblastoma&amp;rft.date=2005&amp;rft.genre=book&amp;rft.isbn=3-540-40841-X&amp;rft.pub=Springer-Verlag&amp;rft.series=p.+63&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlIn_Situ_Neuroblastomas:_a_Contribution_to_the_Natural_History_of_Neural_Crest_Tumors-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlIn_Situ_Neuroblastomas:_a_Contribution_to_the_Natural_History_of_Neural_Crest_Tumors_66-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.pubmedcentral.nih.gov/pagerender.fcgi?artid=1949785&amp;pageindex=1">"In Situ Neuroblastomas: a Contribution to the Natural History of Neural Crest Tumors"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=In+Situ+Neuroblastomas%3A+a+Contribution+to+the+Natural+History+of+Neural+Crest+Tumors&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.pubmedcentral.nih.gov%2Fpagerender.fcgi%3Fartid%3D1949785%26pageindex%3D1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19034443-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19034443_67-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rothenberg AB, Berdon WE, D'Angio GJ, Yamashiro DJ, Cowles RA (February 2009). "Neuroblastoma-remembering the three physicians who described it a century ago: James Homer Wright, William Pepper, and Robert Hutchison". <i>Pediatr Radiol</i> <b>39</b> (2): 155–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00247-008-1062-z">10.1007/s00247-008-1062-z</a>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0301-0449">0301-0449</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19034443">19034443</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Neuroblastoma-remembering+the+three+physicians+who+described+it+a+century+ago%3A+James+Homer+Wright%2C+William+Pepper%2C+and+Robert+Hutchison&amp;rft.aulast=Rothenberg+AB%2C+Berdon+WE%2C+D%27Angio+GJ%2C+Yamashiro+DJ%2C+Cowles+RA&amp;rft.au=Rothenberg+AB%2C+Berdon+WE%2C+D%27Angio+GJ%2C+Yamashiro+DJ%2C+Cowles+RA&amp;rft.date=February+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00247-008-1062-z&amp;rft_id=info%3Apmid%2F19034443&amp;rft.issn=0301-0449&amp;rft.issue=2&amp;rft.jtitle=Pediatr+Radiol&amp;rft.pages=155-60&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=39" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-eagle-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-eagle_68-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.theeagle.com/editorial/Erin-Buenger-had-a-zest-for-living-life-fully">"Erin Buenger had a zest for living life fully, April 12, 2010"</a>. <i>Bryan-College Station Eagle</i><span class="reference-accessdate">. Retrieved <span class="nowrap">October 14,</span> 2010</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Erin+Buenger+had+a+zest+for+living+life+fully%2C+April+12%2C+2010&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.theeagle.com%2Feditorial%2FErin-Buenger-had-a-zest-for-living-life-fully&amp;rft.pub=%27%27Bryan-College+Station+Eagle%27%27&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleNeuroblastoma_Committee_-_Current_Focus_of_Research-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleNeuroblastoma_Committee_-_Current_Focus_of_Research_69-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.curesearch.org/our_research/index_sub.aspx?id=1767">"Neuroblastoma Committee - Current Focus of Research"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-01-13</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Neuroblastoma+Committee+-+Current+Focus+of+Research&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.curesearch.org%2Four_research%2Findex_sub.aspx%3Fid%3D1767&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span><sup class="noprint Inline-Template"><span style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title="&#160;since April 2012">dead link</span></a></i>]</span></sup></span></li>
<li id="cite_note-urlA_phase_III_trial_of_biologically-based_therapy_reduction_for_intermediate_risk_neuroblastoma_--_Baker_et_al._25_.2818_Supplement.29:_9504_--_ASCO_Meeting_Abstracts-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlA_phase_III_trial_of_biologically-based_therapy_reduction_for_intermediate_risk_neuroblastoma_--_Baker_et_al._25_.2818_Supplement.29:_9504_--_ASCO_Meeting_Abstracts_70-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://meeting.ascopubs.org/cgi/content/abstract/25/18_suppl/9504">"A phase III trial of biologically-based therapy reduction for intermediate risk neuroblastoma -- Baker et al. 25 (18 Supplement): 9504 -- ASCO Meeting Abstracts"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=A+phase+III+trial+of+biologically-based+therapy+reduction+for+intermediate+risk+neuroblastoma+--+Baker+et+al.+25+%2818+Supplement%29%3A+9504+--+ASCO+Meeting+Abstracts&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fmeeting.ascopubs.org%2Fcgi%2Fcontent%2Fabstract%2F25%2F18_suppl%2F9504&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20879880-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20879880_71-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK (September 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2993160">"Outcome after reduced chemotherapy for intermediate-risk neuroblastoma"</a>. <i><a href="/wiki/N._Engl._J._Med." title="N. Engl. J. Med." class="mw-redirect">N. Engl. J. Med.</a></i> <b>363</b> (14): 1313–23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa1001527">10.1056/NEJMoa1001527</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2993160">2993160</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20879880">20879880</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Outcome+after+reduced+chemotherapy+for+intermediate-risk+neuroblastoma&amp;rft.au=Baker+DL%2C+Schmidt+ML%2C+Cohn+SL%2C+Maris+JM%2C+London+WB%2C+Buxton+A%2C+Stram+D%2C+Castleberry+RP%2C+Shimada+H%2C+Sandler+A%2C+Shamberger+RC%2C+Look+AT%2C+Reynolds+CP%2C+Seeger+RC%2C+Matthay+KK&amp;rft.aulast=Baker+DL%2C+Schmidt+ML%2C+Cohn+SL%2C+Maris+JM%2C+London+WB%2C+Buxton+A%2C+Stram+D%2C+Castleberry+RP%2C+Shimada+H%2C+Sandler+A%2C+Shamberger+RC%2C+Look+AT%2C+Reynolds+CP%2C+Seeger+RC%2C+Matthay+KK&amp;rft.date=September+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2993160&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1001527&amp;rft_id=info%3Apmc%2F2993160&amp;rft_id=info%3Apmid%2F20879880&amp;rft.issue=14&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1313-23&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=363" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15546135-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15546135_72-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pritchard J, Cotterill SJ, Germond SM, Imeson J, de Kraker J, Jones DR (2005). "High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group". <i>Pediatr Blood Cancer</i> <b>44</b> (4): 348–57. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fpbc.20219">10.1002/pbc.20219</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15546135">15546135</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=High+dose+melphalan+in+the+treatment+of+advanced+neuroblastoma%3A+results+of+a+randomised+trial+%28ENSG-1%29+by+the+European+Neuroblastoma+Study+Group&amp;rft.aulast=Pritchard+J%2C+Cotterill+SJ%2C+Germond+SM%2C+Imeson+J%2C+de+Kraker+J%2C+Jones+DR&amp;rft.au=Pritchard+J%2C+Cotterill+SJ%2C+Germond+SM%2C+Imeson+J%2C+de+Kraker+J%2C+Jones+DR&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fpbc.20219&amp;rft_id=info%3Apmid%2F15546135&amp;rft.issue=4&amp;rft.jtitle=Pediatr+Blood+Cancer&amp;rft.pages=348-57&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=44" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18308250-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18308250_73-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pearson AD, Pinkerton CR, Lewis IJ, Imeson J, Ellershaw C, Machin D (2008). "High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial". <i>Lancet Oncol.</i> <b>9</b> (3): 247–256. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS1470-2045%2808%2970069-X">10.1016/S1470-2045(08)70069-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18308250">18308250</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=High-dose+rapid+and+standard+induction+chemotherapy+for+patients+aged+over+1+year+with+stage+4+neuroblastoma%3A+a+randomised+trial&amp;rft.aulast=Pearson+AD%2C+Pinkerton+CR%2C+Lewis+IJ%2C+Imeson+J%2C+Ellershaw+C%2C+Machin+D&amp;rft.au=Pearson+AD%2C+Pinkerton+CR%2C+Lewis+IJ%2C+Imeson+J%2C+Ellershaw+C%2C+Machin+D&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1470-2045%2808%2970069-X&amp;rft_id=info%3Apmid%2F18308250&amp;rft.issue=3&amp;rft.jtitle=Lancet+Oncol.&amp;rft.pages=247-256&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text"><span class="citation journal">Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP (Oct 1999). <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/pmidlookup?view=short&amp;pmid=10519894&amp;promo=ONFLNS19">"Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group"</a>. <i>N. Engl. J. Med.</i> <b>341</b> (16): 1165–73. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM199910143411601">10.1056/NEJM199910143411601</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10519894">10519894</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Treatment+of+high-risk+neuroblastoma+with+intensive+chemotherapy%2C+radiotherapy%2C+autologous+bone+marrow+transplantation%2C+and+13-cis-retinoic+acid.+Children%27s+Cancer+Group&amp;rft.aulast=Matthay+KK%2C+Villablanca+JG%2C+Seeger+RC%2C+Stram+DO%2C+Harris+RE%2C+Ramsay+NK%2C+Swift+P%2C+Shimada+H%2C+Black+CT%2C+Brodeur+GM%2C+Gerbing+RB%2C+Reynolds+CP&amp;rft.au=Matthay+KK%2C+Villablanca+JG%2C+Seeger+RC%2C+Stram+DO%2C+Harris+RE%2C+Ramsay+NK%2C+Swift+P%2C+Shimada+H%2C+Black+CT%2C+Brodeur+GM%2C+Gerbing+RB%2C+Reynolds+CP&amp;rft.date=Oct+1999&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fpmidlookup%3Fview%3Dshort%26pmid%3D10519894%26promo%3DONFLNS19&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199910143411601&amp;rft_id=info%3Apmid%2F10519894&amp;rft.issue=16&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1165-73&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=341" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19171716-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19171716_75-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG (March 2009). <a rel="nofollow" class="external text" href="http://www.jco.org/cgi/pmidlookup?view=long&amp;pmid=19171716">"Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study"</a>. <i>J. Clin. Oncol.</i> <b>27</b> (7): 1007–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2007.13.8925">10.1200/JCO.2007.13.8925</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2738615">2738615</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19171716">19171716</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Long-term+results+for+children+with+high-risk+neuroblastoma+treated+on+a+randomized+trial+of+myeloablative+therapy+followed+by+13-cis-retinoic+acid%3A+a+children%27s+oncology+group+study&amp;rft.aulast=Matthay+KK%2C+Reynolds+CP%2C+Seeger+RC%2C+Shimada+H%2C+Adkins+ES%2C+Haas-Kogan+D%2C+Gerbing+RB%2C+London+WB%2C+Villablanca+JG&amp;rft.au=Matthay+KK%2C+Reynolds+CP%2C+Seeger+RC%2C+Shimada+H%2C+Adkins+ES%2C+Haas-Kogan+D%2C+Gerbing+RB%2C+London+WB%2C+Villablanca+JG&amp;rft.date=March+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.jco.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D19171716&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2007.13.8925&amp;rft_id=info%3Apmc%2F2738615&amp;rft_id=info%3Apmid%2F19171716&amp;rft.issue=7&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.pages=1007-13&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text"><span class="citation journal">Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J, Klingebiel T, Kremens B, Schilling FH, Schrappe M, Simon T, Hero B (Sep 2005). "Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial". <i>Lancet Oncol.</i> <b>6</b> (9): 649–58. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS1470-2045%2805%2970291-6">10.1016/S1470-2045(05)70291-6</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16129365">16129365</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Myeloablative+megatherapy+with+autologous+stem-cell+rescue+versus+oral+maintenance+chemotherapy+as+consolidation+treatment+in+patients+with+high-risk+neuroblastoma%3A+a+randomised+controlled+trial&amp;rft.au=Berthold+F%2C+Boos+J%2C+Burdach+S%2C+Erttmann+R%2C+Henze+G%2C+Hermann+J%2C+Klingebiel+T%2C+Kremens+B%2C+Schilling+FH%2C+Schrappe+M%2C+Simon+T%2C+Hero+B&amp;rft.aulast=Berthold+F%2C+Boos+J%2C+Burdach+S%2C+Erttmann+R%2C+Henze+G%2C+Hermann+J%2C+Klingebiel+T%2C+Kremens+B%2C+Schilling+FH%2C+Schrappe+M%2C+Simon+T%2C+Hero+B&amp;rft.date=Sep+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1470-2045%2805%2970291-6&amp;rft_id=info%3Apmid%2F16129365&amp;rft.issue=9&amp;rft.jtitle=Lancet+Oncol.&amp;rft.pages=649-58&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleClinical_Trials_.28PDQ.EF.BF.BD.29_-_National_Cancer_Institute-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleClinical_Trials_.28PDQ.EF.BF.BD.29_-_National_Cancer_Institute_77-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/templates/view_clinicaltrials.aspx?version=healthprofessional&amp;cdrid=67429+">"Clinical Trials (PDQ�) - National Cancer Institute"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-02-02</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Clinical+Trials+%28PDQ%EF%BF%BD%29+-+National+Cancer+Institute&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Ftemplates%2Fview_clinicaltrials.aspx%3Fversion%3Dhealthprofessional%26cdrid%3D67429%2B&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Autologous_Stem_Cell_Transplantation_for_High-Risk_Neuroblastoma-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-Autologous_Stem_Cell_Transplantation_for_High-Risk_Neuroblastoma_78-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://mmserver.cjp.com/gems/blood/ABMT.10.Villablanca.pdf">"Autologous Stem Cell Transplantation for High-Risk Neuroblastoma"</a> <span style="font-size:85%;">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-02-02</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Autologous+Stem+Cell+Transplantation+for+High-Risk+Neuroblastoma&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fmmserver.cjp.com%2Fgems%2Fblood%2FABMT.10.Villablanca.pdf&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleNational_Cancer_Institute_-_Clinical-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleNational_Cancer_Institute_-_Clinical_79-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=69018&amp;version=HealthProfessional&amp;protocolsearchid=2119048+">"Clinical Trials - National Cancer Institute"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-02-02</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Clinical+Trials+-+National+Cancer+Institute&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fsearch%2FViewClinicalTrials.aspx%3Fcdrid%3D69018%26version%3DHealthProfessional%26protocolsearchid%3D2119048%2B&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleConsolidation_Treatment_With_Chimeric_Anti-GD2-Antibody_ch14.18_in_Children_Older_Than_1_Year_With_Metastatic_Neuroblastoma_--_Simon_et_al._22_.2817.29:_3549_--_Journal_of_Clinical_Oncology-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleConsolidation_Treatment_With_Chimeric_Anti-GD2-Antibody_ch14.18_in_Children_Older_Than_1_Year_With_Metastatic_Neuroblastoma_--_Simon_et_al._22_.2817.29:_3549_--_Journal_of_Clinical_Oncology_80-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://jco.ascopubs.org/cgi/content/full/22/17/3549">"Consolidation Treatment With Chimeric Anti-GD2-Antibody ch14.18 in Children Older Than 1 Year With Metastatic Neuroblastoma -- Simon et al. 22 (17): 3549 -- Journal of Clinical Oncology"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-02-02</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Consolidation+Treatment+With+Chimeric+Anti-GD2-Antibody+ch14.18+in+Children+Older+Than+1+Year+With+Metastatic+Neuroblastoma+--+Simon+et+al.+22+%2817%29%3A+3549+--+Journal+of+Clinical+Oncology&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fjco.ascopubs.org%2Fcgi%2Fcontent%2Ffull%2F22%2F17%2F3549&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlNCI_Cancer_Bulletin_for_May_19.2C_2009_-_National_Cancer_Institute-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlNCI_Cancer_Bulletin_for_May_19.2C_2009_-_National_Cancer_Institute_81-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/ncicancerbulletin/051909/page2">"NCI Cancer Bulletin for May 19, 2009 - National Cancer Institute"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=NCI+Cancer+Bulletin+for+May+19%2C+2009+-+National+Cancer+Institute&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fncicancerbulletin%2F051909%2Fpage2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlMonoclonal_Antibody_Ch14.18.2C_Sargramostim.2C_Aldesleukin.2C_and_Isotretinoin_After_Autologous_Stem_Cell_Transplant_in_Treating_Patients_With_Neuroblastoma_-_Full_Text_View_-_ClinicalTrials.gov-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlMonoclonal_Antibody_Ch14.18.2C_Sargramostim.2C_Aldesleukin.2C_and_Isotretinoin_After_Autologous_Stem_Cell_Transplant_in_Treating_Patients_With_Neuroblastoma_-_Full_Text_View_-_ClinicalTrials.gov_82-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://clinicaltrials.gov/ct2/show/NCT01041638">"Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma - Full Text View - ClinicalTrials.gov"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Monoclonal+Antibody+Ch14.18%2C+Sargramostim%2C+Aldesleukin%2C+and+Isotretinoin+After+Autologous+Stem+Cell+Transplant+in+Treating+Patients+With+Neuroblastoma+-+Full+Text+View+-+ClinicalTrials.gov&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01041638&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SIOP_Neuroblastoma_Education_Book-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-SIOP_Neuroblastoma_Education_Book_83-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cure4kids.org/private/courses_documents/m_148/SIOP-2005-Education-Book.pdf">"Neuroblastoma Education Book"</a> <span style="font-size:85%;">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-02-02</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Neuroblastoma+Education+Book&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cure4kids.org%2Fprivate%2Fcourses_documents%2Fm_148%2FSIOP-2005-Education-Book.pdf&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleTrials_-_National_Cancer_Institute-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleTrials_-_National_Cancer_Institute_84-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=69191&amp;version=HealthProfessional&amp;protocolsearchid=4015135">"Clinical Trials (PDQ�) - National Cancer Institute"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-02-02</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Clinical+Trials+%28PDQ%EF%BF%BD%29+-+National+Cancer+Institute&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fsearch%2FViewClinicalTrials.aspx%3Fcdrid%3D69191%26version%3DHealthProfessional%26protocolsearchid%3D4015135&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20567002-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20567002_85-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ladenstein R, Valteau-Couanet D, Brock P, Yaniv I, Castel V, Laureys G, Malis J, Papadakis V, Lacerda A, Ruud E, Kogner P, Garami M, Balwierz W, Schroeder H, Beck-Popovic M, Schreier G, Machin D, Pötschger U, Pearson A (July 2010). "Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study". <i>J. Clin. Oncol.</i> <b>28</b> (21): 3516–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2009.27.3524">10.1200/JCO.2009.27.3524</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20567002">20567002</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Randomized+Trial+of+prophylactic+granulocyte+colony-stimulating+factor+during+rapid+COJEC+induction+in+pediatric+patients+with+high-risk+neuroblastoma%3A+the+European+HR-NBL1%2FSIOPEN+study&amp;rft.au=Ladenstein+R%2C+Valteau-Couanet+D%2C+Brock+P%2C+Yaniv+I%2C+Castel+V%2C+Laureys+G%2C+Malis+J%2C+Papadakis+V%2C+Lacerda+A%2C+Ruud+E%2C+Kogner+P%2C+Garami+M%2C+Balwierz+W%2C+Schroeder+H%2C+Beck-Popovic+M%2C+Schreier+G%2C+Machin+D%2C+P%C3%B6tschger+U%2C+Pearson+A&amp;rft.aulast=Ladenstein+R%2C+Valteau-Couanet+D%2C+Brock+P%2C+Yaniv+I%2C+Castel+V%2C+Laureys+G%2C+Malis+J%2C+Papadakis+V%2C+Lacerda+A%2C+Ruud+E%2C+Kogner+P%2C+Garami+M%2C+Balwierz+W%2C+Schroeder+H%2C+Beck-Popovic+M%2C+Schreier+G%2C+Machin+D%2C+P%C3%B6tschger+U%2C+Pearson+A&amp;rft.date=July+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2009.27.3524&amp;rft_id=info%3Apmid%2F20567002&amp;rft.issue=21&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.pages=3516-24&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=28" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlObservation.2C_Combination_Chemotherapy.2C_Radiation_Therapy.2C_and.2For_Autologous_Stem_Cell_Transplant_in_Treating_Young_Patients_With_Neuroblastoma_-_Full_Text_View_-_ClinicalTrials.gov-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlObservation.2C_Combination_Chemotherapy.2C_Radiation_Therapy.2C_and.2For_Autologous_Stem_Cell_Transplant_in_Treating_Young_Patients_With_Neuroblastoma_-_Full_Text_View_-_ClinicalTrials.gov_86-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://clinicaltrials.gov/ct2/show/NCT00410631">"Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma - Full Text View - ClinicalTrials.gov"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Observation%2C+Combination+Chemotherapy%2C+Radiation+Therapy%2C+and%2For+Autologous+Stem+Cell+Transplant+in+Treating+Young+Patients+With+Neuroblastoma+-+Full+Text+View+-+ClinicalTrials.gov&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00410631&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlClinical_Trials_.28PDQ.C2.AE.29_-_National_Cancer_Institute-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlClinical_Trials_.28PDQ.C2.AE.29_-_National_Cancer_Institute_87-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.gov/clinicaltrials/search/view?cdrid=576571&amp;version=HealthProfessional&amp;protocolsearchid=8771802">"Clinical Trials (PDQ®) - National Cancer Institute"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Clinical+Trials+%28PDQ%C2%AE%29+-+National+Cancer+Institute&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fclinicaltrials%2Fsearch%2Fview%3Fcdrid%3D576571%26version%3DHealthProfessional%26protocolsearchid%3D8771802&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><span class="citation journal">George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, Pulsipher M, Grupp SA, Diller L (Jun 2006). "High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update". <i>J. Clin. Oncol.</i> <b>24</b> (18): 2891–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2006.05.6986">10.1200/JCO.2006.05.6986</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16782928">16782928</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=High-risk+neuroblastoma+treated+with+tandem+autologous+peripheral-blood+stem+cell-supported+transplantation%3A+long-term+survival+update&amp;rft.au=George+RE%2C+Li+S%2C+Medeiros-Nancarrow+C%2C+Neuberg+D%2C+Marcus+K%2C+Shamberger+RC%2C+Pulsipher+M%2C+Grupp+SA%2C+Diller+L&amp;rft.aulast=George+RE%2C+Li+S%2C+Medeiros-Nancarrow+C%2C+Neuberg+D%2C+Marcus+K%2C+Shamberger+RC%2C+Pulsipher+M%2C+Grupp+SA%2C+Diller+L&amp;rft.date=Jun+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2006.05.6986&amp;rft_id=info%3Apmid%2F16782928&amp;rft.issue=18&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.pages=2891-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleNeuroblastoma_Protocol_2005:_Therapy_for_Children_with_Advanced_Stage_High-Risk_Neuroblastoma-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleNeuroblastoma_Protocol_2005:_Therapy_for_Children_with_Advanced_Stage_High-Risk_Neuroblastoma_89-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://clinicaltrial.gov/ct2/show/NCT00135135?intr=%22Tazarotene%22&amp;show_desc=Y#desc">"Neuroblastoma Protocol 2005: Therapy for Children with Advanced Stage High-Risk Neuroblastoma"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-02-02</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Neuroblastoma+Protocol+2005%3A+Therapy+for+Children+with+Advanced+Stage+High-Risk+Neuroblastoma&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fclinicaltrial.gov%2Fct2%2Fshow%2FNCT00135135%3Fintr%3D%2522Tazarotene%2522%26show_desc%3DY%23desc&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleSloan-Kettering_-_Neuroblastoma:_Our_Clinical_Trials-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleSloan-Kettering_-_Neuroblastoma:_Our_Clinical_Trials_90-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.mskcc.org/mskcc/html/63090.cfm">"Sloan-Kettering - Neuroblastoma: Our Clinical Trials"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-02-02</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Sloan-Kettering+-+Neuroblastoma%3A+Our+Clinical+Trials&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.mskcc.org%2Fmskcc%2Fhtml%2F63090.cfm&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlInduction_Therapy_Followed_by_131_I-MIBG_and_High-Dose_Chemotherapy_in_Treating_Patients_With_Newly_Diagnosed_High-Risk_Neuroblastoma_Undergoing_Stem_Cell_Transplant.2C_Radiation_Therapy.2C_and_Maintenance_Therapy_With_Isotretinoin_-_Full_Text_View_-_ClinicalTrials.gov-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlInduction_Therapy_Followed_by_131_I-MIBG_and_High-Dose_Chemotherapy_in_Treating_Patients_With_Newly_Diagnosed_High-Risk_Neuroblastoma_Undergoing_Stem_Cell_Transplant.2C_Radiation_Therapy.2C_and_Maintenance_Therapy_With_Isotretinoin_-_Full_Text_View_-_ClinicalTrials.gov_91-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://clinicaltrials.gov/ct2/show/NCT01175356">"Induction Therapy Followed by 131 I-MIBG and High-Dose Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin - Full Text View - ClinicalTrials.gov"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Induction+Therapy+Followed+by+131+I-MIBG+and+High-Dose+Chemotherapy+in+Treating+Patients+With+Newly+Diagnosed+High-Risk+Neuroblastoma+Undergoing+Stem+Cell+Transplant%2C+Radiation+Therapy%2C+and+Maintenance+Therapy+With+Isotretinoin+-+Full+Text+View+-+ClinicalTrials.gov&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01175356&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleRecurrent_neuroblastoma:_Randomized_treatment_with_topotecan_.2B_cyclophosphamide_.28T.2BC.29_vs._topotecan_alone.28T.29._A_POG.2FCCG_Intergroup_Study_--_Frantz_et_al._22_.2814_Supplement.29:_8512_--_ASCO_Meeting_Abstracts-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleRecurrent_neuroblastoma:_Randomized_treatment_with_topotecan_.2B_cyclophosphamide_.28T.2BC.29_vs._topotecan_alone.28T.29._A_POG.2FCCG_Intergroup_Study_--_Frantz_et_al._22_.2814_Supplement.29:_8512_--_ASCO_Meeting_Abstracts_92-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://meeting.ascopubs.org/cgi/content/abstract/22/14_suppl/8512">"Recurrent neuroblastoma: Randomized treatment with topotecan + cyclophosphamide (T+C) vs. topotecan alone(T). A POG/CCG Intergroup Study -- Frantz et al. 22 (14 Supplement): 8512 -- ASCO Meeting Abstracts"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-03-13</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Recurrent+neuroblastoma%3A+Randomized+treatment+with+topotecan+%2B+cyclophosphamide+%28T%2BC%29+vs.+topotecan+alone%28T%29.+A+POG%2FCCG+Intergroup+Study+--+Frantz+et+al.+22+%2814+Supplement%29%3A+8512+--+ASCO+Meeting+Abstracts&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fmeeting.ascopubs.org%2Fcgi%2Fcontent%2Fabstract%2F22%2F14_suppl%2F8512&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleIrinotecan_Plus_Temozolomide_for_Relapsed_or_Refractory_Neuroblastoma_--_Kushner_et_al._24_.2833.29:_5271_--_Journal_of_Clinical_Oncology-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleIrinotecan_Plus_Temozolomide_for_Relapsed_or_Refractory_Neuroblastoma_--_Kushner_et_al._24_.2833.29:_5271_--_Journal_of_Clinical_Oncology_93-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://jco.ascopubs.org/cgi/content/full/24/33/5271">"Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma -- Kushner et al. 24 (33): 5271 -- Journal of Clinical Oncology"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-03-13</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Irinotecan+Plus+Temozolomide+for+Relapsed+or+Refractory+Neuroblastoma+--+Kushner+et+al.+24+%2833%29%3A+5271+--+Journal+of+Clinical+Oncology&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fjco.ascopubs.org%2Fcgi%2Fcontent%2Ffull%2F24%2F33%2F5271&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titlePhase_I_study_of_oral_irinotecan_and_temozolomide_in_children_with_relapsed_high-risk_neuroblastoma:_A_New_Approach_to_Neuroblastoma_Therapy_.28NANT.29_Consortium_study_--_Wagner_et_al._25_.2818_Supplement.29:_9567_--_ASCO_Meeting_Abstracts-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-titlePhase_I_study_of_oral_irinotecan_and_temozolomide_in_children_with_relapsed_high-risk_neuroblastoma:_A_New_Approach_to_Neuroblastoma_Therapy_.28NANT.29_Consortium_study_--_Wagner_et_al._25_.2818_Supplement.29:_9567_--_ASCO_Meeting_Abstracts_94-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://meeting.ascopubs.org/cgi/content/abstract/25/18_suppl/9567">"Phase I study of oral irinotecan and temozolomide in children with relapsed high-risk neuroblastoma: A New Approach to Neuroblastoma Therapy (NANT) Consortium study -- Wagner et al. 25 (18 Supplement): 9567 -- ASCO Meeting Abstracts"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-03-13</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Phase+I+study+of+oral+irinotecan+and+temozolomide+in+children+with+relapsed+high-risk+neuroblastoma%3A+A+New+Approach+to+Neuroblastoma+Therapy+%28NANT%29+Consortium+study+--+Wagner+et+al.+25+%2818+Supplement%29%3A+9567+--+ASCO+Meeting+Abstracts&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fmeeting.ascopubs.org%2Fcgi%2Fcontent%2Fabstract%2F25%2F18_suppl%2F9567&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-titleNANT_Home_Page-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-titleNANT_Home_Page_95-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.nant.org/">"NANT Home Page"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2008-02-02</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=NANT+Home+Page&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nant.org%2F&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlHome_-_Neuroblastoma_and_Medulloblastoma_Translational_Research_Consortium-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlHome_-_Neuroblastoma_and_Medulloblastoma_Translational_Research_Consortium_96-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.nmtrc.org/">"Home - Neuroblastoma and Medulloblastoma Translational Research Consortium"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Home+-+Neuroblastoma+and+Medulloblastoma+Translational+Research+Consortium&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nmtrc.org%2F&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlHaploidentical_Stem_Cell_Transplantation_in_Neuroblastoma_-_Full_Text_View_-_ClinicalTrials.gov-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlHaploidentical_Stem_Cell_Transplantation_in_Neuroblastoma_-_Full_Text_View_-_ClinicalTrials.gov_97-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://clinicaltrials.gov/ct2/show/NCT00790413">"Haploidentical Stem Cell Transplantation in Neuroblastoma - Full Text View - ClinicalTrials.gov"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.btitle=Haploidentical+Stem+Cell+Transplantation+in+Neuroblastoma+-+Full+Text+View+-+ClinicalTrials.gov&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00790413&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17974978-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17974978_98-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Xue C, Haber M, Flemming C, Marshall GM, Lock RB, MacKenzie KL, Gurova KV, Norris MD, Gudkov AV (2007). <a rel="nofollow" class="external text" href="http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&amp;pmid=17974978">"p53 determines multidrug sensitivity of childhood neuroblastoma"</a>. <i>Cancer Res.</i> <b>67</b> (21): 10351–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1158%2F0008-5472.CAN-06-4345">10.1158/0008-5472.CAN-06-4345</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17974978">17974978</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=p53+determines+multidrug+sensitivity+of+childhood+neuroblastoma&amp;rft.aulast=Xue+C%2C+Haber+M%2C+Flemming+C%2C+Marshall+GM%2C+Lock+RB%2C+MacKenzie+KL%2C+Gurova+KV%2C+Norris+MD%2C+Gudkov+AV&amp;rft.au=Xue+C%2C+Haber+M%2C+Flemming+C%2C+Marshall+GM%2C+Lock+RB%2C+MacKenzie+KL%2C+Gurova+KV%2C+Norris+MD%2C+Gudkov+AV&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcancerres.aacrjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D17974978&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-06-4345&amp;rft_id=info%3Apmid%2F17974978&amp;rft.issue=21&amp;rft.jtitle=Cancer+Res.&amp;rft.pages=10351-60&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=67" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19903807-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19903807_99-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Van Maerken T, Ferdinande L, Taildeman J, Lambertz I, Yigit N, Vercruysse L, Rihani A, Michaelis M, Cinatl J, Cuvelier CA, Marine JC, De Paepe A, Bracke M, Speleman F, Vandesompele J (November 2009). <a rel="nofollow" class="external text" href="http://jnci.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=19903807">"Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53"</a>. <i>Journal of the National Cancer Institute</i> <b>101</b> (22): 1562–1574. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fjnci%2Fdjp355">10.1093/jnci/djp355</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19903807">19903807</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroblastoma&amp;rft.atitle=Antitumor+Activity+of+the+Selective+MDM2+Antagonist+Nutlin-3+Against+Chemoresistant+Neuroblastoma+With+Wild-Type+p53&amp;rft.aulast=Van+Maerken+T%2C+Ferdinande+L%2C+Taildeman+J%2C+Lambertz+I%2C+Yigit+N%2C+Vercruysse+L%2C+Rihani+A%2C+Michaelis+M%2C+Cinatl+J%2C+Cuvelier+CA%2C+Marine+JC%2C+De+Paepe+A%2C+Bracke+M%2C+Speleman+F%2C+Vandesompele+J&amp;rft.au=Van+Maerken+T%2C+Ferdinande+L%2C+Taildeman+J%2C+Lambertz+I%2C+Yigit+N%2C+Vercruysse+L%2C+Rihani+A%2C+Michaelis+M%2C+Cinatl+J%2C+Cuvelier+CA%2C+Marine+JC%2C+De+Paepe+A%2C+Bracke+M%2C+Speleman+F%2C+Vandesompele+J&amp;rft.date=November+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjnci.oxfordjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D19903807&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjp355&amp;rft_id=info%3Apmid%2F19903807&amp;rft.issue=22&amp;rft.jtitle=Journal+of+the+National+Cancer+Institute&amp;rft.pages=1562-1574&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=101" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit&amp;section=21" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="https://www.dmoz.org/Health/Conditions_and_Diseases/Cancer/Brain_and_CNS/Neuroblastoma/">Neuroblastoma</a> at <a href="/wiki/DMOZ" title="DMOZ">DMOZ</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Small_blue_round_cell_tumors" title="Template:Small blue round cell tumors"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Small_blue_round_cell_tumors" title="Template talk:Small blue round cell tumors"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Small_blue_round_cell_tumors&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Small-blue-round-cell_tumor" title="Small-blue-round-cell tumor">Small-blue-round-cell tumors</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/B-cell_chronic_lymphocytic_leukemia" title="B-cell chronic lymphocytic leukemia">B-cell chronic lymphocytic leukemia</a></li>
<li><a href="/wiki/Hepatoblastoma" title="Hepatoblastoma">Hepatoblastoma</a></li>
<li><a href="/wiki/Rhabdomyosarcoma" title="Rhabdomyosarcoma">Rhabdomyosarcoma</a></li>
<li><a href="/wiki/Ewing%27s_sarcoma" title="Ewing's sarcoma">Ewing's sarcoma</a></li>
<li><strong class="selflink">Neuroblastoma</strong></li>
<li><a href="/wiki/Retinoblastoma" title="Retinoblastoma">Retinoblastoma</a></li>
<li><a href="/wiki/Wilms%27_tumor" title="Wilms' tumor">Wilms' tumor</a></li>
<li><a href="/wiki/Desmoplastic_small_round_cell_tumor" title="Desmoplastic small round cell tumor" class="mw-redirect">Desmoplastic small round cell tumor</a></li>
<li><a href="/wiki/Medulloblastoma" title="Medulloblastoma">Medulloblastoma</a></li>
<li><a href="/wiki/Primitive_neuroectodermal_tumor" title="Primitive neuroectodermal tumor">Primitive neuroectodermal tumor</a> (<b>PNET</b>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Nervous_system_tumors" title="Template:Nervous system tumors"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Nervous_system_tumors" title="Template talk:Nervous system tumors"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Nervous_system_tumors&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Nervous_tissue" title="Nervous tissue">Nervous tissue</a> <a href="/wiki/Neoplasm" title="Neoplasm">tumors</a>/<a href="/wiki/Nervous_system_neoplasm" title="Nervous system neoplasm">NS neoplasm</a>/<a href="/wiki/Neuroectodermal_tumor" title="Neuroectodermal tumor">Neuroectodermal tumor</a> (<a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a> 9350–9589) (<a href="/wiki/ICD-10_Chapter_II:_Neoplasms#.28C69.E2.80.93C72.29_Malignant_neoplasms.2C_eye.2C_brain_and_central_nervous_system" title="ICD-10 Chapter II: Neoplasms">C70–C72, D32–D33</a>, <a href="/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_other_and_unspecified_sites_.28190.E2.80.93199.29" title="List of ICD-9 codes 140–239: neoplasms">191–192/225</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Endocrine_gland_neoplasm" title="Endocrine gland neoplasm">Endocrine</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/WHO_classification_of_the_tumors_of_the_central_nervous_system#6._Tumours_of_the_sellar_region" title="WHO classification of the tumors of the central nervous system">Sellar</a>:</i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Craniopharyngioma" title="Craniopharyngioma">Craniopharyngioma</a></li>
<li><a href="/wiki/Pituicytoma" title="Pituicytoma">Pituicytoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i>Other:</i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Pinealoma" title="Pinealoma">Pinealoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Central_nervous_system" title="Central nervous system">CNS</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/WHO_classification_of_the_tumors_of_the_central_nervous_system#1._Tumours_of_neuroepithelial_tissue" title="WHO classification of the tumors of the central nervous system">Neuroepithelial</a><br />
(<a href="/wiki/Brain_tumor" title="Brain tumor">brain tumors</a>,<br />
<a href="/wiki/Spinal_tumor" title="Spinal tumor">spinal tumors</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Glioma" title="Glioma">Glioma</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Astrocyte" title="Astrocyte">Astrocyte</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Astrocytoma" title="Astrocytoma">Astrocytoma</a>
<ul>
<li><a href="/wiki/Pilocytic_astrocytoma" title="Pilocytic astrocytoma">Pilocytic astrocytoma</a></li>
<li><a href="/wiki/Pleomorphic_xanthoastrocytoma" title="Pleomorphic xanthoastrocytoma">Pleomorphic xanthoastrocytoma</a></li>
<li><a href="/wiki/Subependymal_giant_cell_astrocytoma" title="Subependymal giant cell astrocytoma">Subependymal giant cell astrocytoma</a></li>
<li><a href="/wiki/Fibrillary_astrocytoma" title="Fibrillary astrocytoma">Fibrillary astrocytoma</a></li>
<li><a href="/wiki/Anaplastic_astrocytoma" title="Anaplastic astrocytoma">Anaplastic astrocytoma</a></li>
<li><a href="/wiki/Glioblastoma_multiforme" title="Glioblastoma multiforme">Glioblastoma multiforme</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Oligodendrocyte" title="Oligodendrocyte">Oligodendrocyte</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Oligodendroglioma" title="Oligodendroglioma">Oligodendroglioma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Ependyma" title="Ependyma">Ependyma</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Ependymoma" title="Ependymoma">Ependymoma</a></li>
<li><a href="/wiki/Subependymoma" title="Subependymoma">Subependymoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Choroid_plexus" title="Choroid plexus">Choroid plexus</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Choroid_plexus_tumor" title="Choroid plexus tumor">Choroid plexus tumor</a>
<ul>
<li><a href="/wiki/Choroid_plexus_papilloma" title="Choroid plexus papilloma">Choroid plexus papilloma</a></li>
<li><a href="/wiki/Choroid_plexus_carcinoma" title="Choroid plexus carcinoma">Choroid plexus carcinoma</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Multiple/unknown</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Oligoastrocytoma" title="Oligoastrocytoma">Oligoastrocytoma</a></li>
<li><a href="/wiki/Gliomatosis_cerebri" title="Gliomatosis cerebri">Gliomatosis cerebri</a></li>
<li><a href="/wiki/Gliosarcoma" title="Gliosarcoma">Gliosarcoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Mature<br />
<a href="/wiki/Neuron" title="Neuron">neuron</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Ganglioneuroma" title="Ganglioneuroma">Ganglioneuroma</a>: <a href="/wiki/Ganglioglioma" title="Ganglioglioma">Ganglioglioma</a></li>
<li><a href="/wiki/Retinoblastoma" title="Retinoblastoma">Retinoblastoma</a></li>
<li><a href="/wiki/Neurocytoma" title="Neurocytoma">Neurocytoma</a></li>
<li><a href="/wiki/Dysembryoplastic_neuroepithelial_tumour" title="Dysembryoplastic neuroepithelial tumour">Dysembryoplastic neuroepithelial tumour</a></li>
<li><a href="/wiki/Lhermitte%E2%80%93Duclos_disease" title="Lhermitte–Duclos disease">Lhermitte–Duclos disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Primitive_neuroectodermal_tumor" title="Primitive neuroectodermal tumor">PNET</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><strong class="selflink">Neuroblastoma</strong>
<ul>
<li><a href="/wiki/Esthesioneuroblastoma" title="Esthesioneuroblastoma">Esthesioneuroblastoma</a></li>
<li><a href="/wiki/Ganglioneuroblastoma" title="Ganglioneuroblastoma">Ganglioneuroblastoma</a></li>
</ul>
</li>
<li><a href="/wiki/Medulloblastoma" title="Medulloblastoma">Medulloblastoma</a></li>
<li><a href="/wiki/Atypical_teratoid_rhabdoid_tumor" title="Atypical teratoid rhabdoid tumor">Atypical teratoid rhabdoid tumor</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Primitive</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Medulloepithelioma" title="Medulloepithelioma">Medulloepithelioma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Meningiomas<br />
(<a href="/wiki/Meninges" title="Meninges">Meninges</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Meningioma" title="Meningioma">Meningioma</a></li>
<li><a href="/wiki/Hemangiopericytoma" title="Hemangiopericytoma">Hemangiopericytoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/WHO_classification_of_the_tumors_of_the_central_nervous_system#4._Tumors_of_the_haematopoietic_system" title="WHO classification of the tumors of the central nervous system">Hematopoietic</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Primary_central_nervous_system_lymphoma" title="Primary central nervous system lymphoma">Primary central nervous system lymphoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Peripheral_nervous_system" title="Peripheral nervous system">PNS</a>: <a href="/wiki/Nerve_sheath_tumor" title="Nerve sheath tumor">NST</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/WHO_classification_of_the_tumors_of_the_central_nervous_system#2._Tumours_of_cranial_and_paraspinal_nerves" title="WHO classification of the tumors of the central nervous system">Cranial and paraspinal nerves</a>:</i> <a href="/wiki/Neurofibroma" title="Neurofibroma">Neurofibroma</a>
<ul>
<li><a href="/wiki/Neurofibrosarcoma" title="Neurofibrosarcoma" class="mw-redirect">Neurofibrosarcoma</a></li>
<li><a href="/wiki/Neurofibromatosis" title="Neurofibromatosis">Neurofibromatosis</a></li>
</ul>
</li>
<li><a href="/wiki/Neurilemmoma" title="Neurilemmoma" class="mw-redirect">Neurilemmoma</a>/<a href="/wiki/Schwannoma" title="Schwannoma">Schwannoma</a>
<ul>
<li><a href="/wiki/Vestibular_schwannoma" title="Vestibular schwannoma">Acoustic neuroma</a></li>
</ul>
</li>
<li><a href="/wiki/Malignant_peripheral_nerve_sheath_tumor" title="Malignant peripheral nerve sheath tumor">Malignant peripheral nerve sheath tumor</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<div><i>Note: Not all brain tumors are of nervous tissue, and not all nervous tissue tumors are in the brain (see <a href="/wiki/Brain_metastasis" title="Brain metastasis">brain metastasis</a>).</i><br /></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Central_nervous_system_navs" title="Template:Central nervous system navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Central_nervous_system_navs" title="Template talk:Central nervous system navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Central_nervous_system_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of the <a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Nervous_system" title="Template:Nervous system">Anatomy</a>
<ul>
<li><a href="/wiki/Template:Meninges" title="Template:Meninges">meninges</a></li>
<li><a href="/wiki/Template:Cerebral_cortex" title="Template:Cerebral cortex">cortex</a>
<ul>
<li><i><a href="/wiki/Template:Association_fibers" title="Template:Association fibers">association fibers</a></i></li>
<li><i><a href="/wiki/Template:Commissural_fibers_and_septum" title="Template:Commissural fibers and septum">commissural fibers</a></i></li>
</ul>
</li>
<li><a href="/wiki/Template:Lateral_ventricles" title="Template:Lateral ventricles" class="mw-redirect">lateral ventricles</a></li>
<li><a href="/wiki/Template:Rostral_basal_ganglia_and_associated_structures" title="Template:Rostral basal ganglia and associated structures">basal ganglia</a></li>
<li><a href="/wiki/Template:Diencephalon" title="Template:Diencephalon">diencephalon</a></li>
<li><a href="/wiki/Template:Mesencephalon" title="Template:Mesencephalon">mesencephalon</a></li>
<li><a href="/wiki/Template:Pons" title="Template:Pons">pons</a></li>
<li><a href="/wiki/Template:Cerebellum" title="Template:Cerebellum">cerebellum</a></li>
<li><a href="/wiki/Template:Medulla" title="Template:Medulla">medulla</a></li>
<li><a href="/wiki/Template:Spinal_cord" title="Template:Spinal cord">spinal cord</a>
<ul>
<li><i><a href="/wiki/Template:Neural_tracts" title="Template:Neural tracts">tracts</a></i></li>
</ul>
</li>
</ul>
</li>
<li><a href="/wiki/Template:Nervous_system_physiology" title="Template:Nervous system physiology">Physiology</a>
<ul>
<li><a href="/wiki/Template:Neurotransmitter_systems" title="Template:Neurotransmitter systems">neutrotransmission</a>
<ul>
<li><i><a href="/wiki/Template:Neurotransmitter_metabolism_enzymes" title="Template:Neurotransmitter metabolism enzymes">enzymes</a></i></li>
<li><i><a href="/wiki/Template:Neurotransmitter_metabolism_intermediates" title="Template:Neurotransmitter metabolism intermediates">intermediates</a></i></li>
</ul>
</li>
</ul>
</li>
<li><a href="/wiki/Template:Development_of_nervous_system" title="Template:Development of nervous system">Development</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Cerebral_palsy" title="Template:Cerebral palsy">Cerebral palsy</a></li>
<li><a href="/wiki/Template:Diseases_of_meninges" title="Template:Diseases of meninges">Meningitis</a></li>
<li><a href="/wiki/Template:Demyelinating_diseases_of_CNS" title="Template:Demyelinating diseases of CNS">Demyelinating diseases</a></li>
<li><a href="/wiki/Template:Seizures_and_epilepsy" title="Template:Seizures and epilepsy">Seizures and epilepsy</a></li>
<li><a href="/wiki/Template:Headache" title="Template:Headache">Headache</a></li>
<li><a href="/wiki/Template:Cerebrovascular_diseases" title="Template:Cerebrovascular diseases">Stroke</a></li>
<li><a href="/wiki/Template:Sleep" title="Template:Sleep">Sleep</a></li>
<li><a href="/wiki/Template:Congenital_malformations_and_deformations_of_nervous_system" title="Template:Congenital malformations and deformations of nervous system">Congenital</a></li>
<li><a href="/wiki/Template:Neurotrauma" title="Template:Neurotrauma">Injury</a></li>
<li><a href="/wiki/Template:Nervous_system_tumors" title="Template:Nervous system tumors">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:CNS_diseases_of_the_nervous_system" title="Template:CNS diseases of the nervous system">Other</a>
<ul>
<li><a href="/wiki/Template:Cerebral_palsy_and_other_paralytic_syndromes" title="Template:Cerebral palsy and other paralytic syndromes">paralytic syndromes</a></li>
<li><a href="/wiki/Template:Amyotrophic_lateral_sclerosis" title="Template:Amyotrophic lateral sclerosis">ALS</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Nervous_and_musculoskeletal_system_symptoms_and_signs" title="Template:Nervous and musculoskeletal system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Symptoms_involving_head_and_neck" title="Template:Symptoms involving head and neck">head and neck</a></li>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_nervous_system" title="Template:Eponymous medical signs for nervous system">eponymous</a></li>
<li><a href="/wiki/Template:Lesions_of_spinal_cord_and_brain" title="Template:Lesions of spinal cord and brain">lesions</a></li>
</ul>
</li>
<li>Tests
<ul>
<li><a href="/wiki/Template:CSF_tests" title="Template:CSF tests">CSF</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Neuro_procedures" title="Template:Neuro procedures">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:General_anesthetics" title="Template:General anesthetics">general anesthetics</a></li>
<li><a href="/wiki/Template:Analgesics" title="Template:Analgesics">analgesics</a></li>
<li><a href="/wiki/Template:Antiaddictives" title="Template:Antiaddictives" class="mw-redirect">addiction</a></li>
<li><a href="/wiki/Template:Anticonvulsants" title="Template:Anticonvulsants">epilepsy</a></li>
<li><a href="/wiki/Template:Cholinergics" title="Template:Cholinergics">cholinergics</a></li>
<li><a href="/wiki/Template:Antimigraine_preparations" title="Template:Antimigraine preparations">migraine</a></li>
<li><a href="/wiki/Template:Antiparkinson" title="Template:Antiparkinson">Parkinson's</a></li>
<li><a href="/wiki/Template:Antivertigo_preparations" title="Template:Antivertigo preparations">vertigo</a></li>
<li><a href="/wiki/Template:Other_nervous_system_drugs" title="Template:Other nervous system drugs">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Peripheral_nervous_system_navs" title="Template:Peripheral nervous system navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Peripheral_nervous_system_navs" title="Template talk:Peripheral nervous system navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Peripheral_nervous_system_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of the <a href="/wiki/Peripheral_nervous_system" title="Peripheral nervous system">peripheral nervous system</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Nervous_system" title="Template:Nervous system">Anatomy</a></li>
<li><a href="/wiki/Template:Nervous_tissue" title="Template:Nervous tissue">Nerves</a>
<ul>
<li><a href="/wiki/Template:Cranial_nerves" title="Template:Cranial nerves">cranial</a></li>
<li><a href="/wiki/Template:Trigeminal_nerve" title="Template:Trigeminal nerve">trigeminal</a></li>
<li><a href="/wiki/Template:Cervical_plexus" title="Template:Cervical plexus">cervical</a></li>
<li><a href="/wiki/Template:Brachial_plexus" title="Template:Brachial plexus">brachial</a></li>
<li><a href="/wiki/Template:Lumbosacral_plexus" title="Template:Lumbosacral plexus">lumbosacral plexus</a></li>
<li><a href="/wiki/Template:Somatosensory_system" title="Template:Somatosensory system">somatosensory</a></li>
<li><a href="/wiki/Template:Spinal_nerves" title="Template:Spinal nerves">spinal</a></li>
<li><a href="/wiki/Template:Autonomic_nervous_system" title="Template:Autonomic nervous system">autonomic</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Nervous_system_physiology" title="Template:Nervous system physiology">Physiology</a>
<ul>
<li><a href="/wiki/Template:Reflex" title="Template:Reflex">reflexes</a></li>
<li><a href="/wiki/Template:Nerve_tissue_protein" title="Template:Nerve tissue protein">proteins</a></li>
<li><a href="/wiki/Template:Neurotransmitters" title="Template:Neurotransmitters">neurotransmitters</a></li>
<li><a href="/wiki/Template:Neurotransmitter_transporters" title="Template:Neurotransmitter transporters">transporters</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Development_of_nervous_system" title="Template:Development of nervous system">Development</a>
<ul>
<li><a href="/wiki/Template:Neurotrophins" title="Template:Neurotrophins">neurotrophins</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Autonomic_diseases" title="Template:Autonomic diseases">Autonomic</a></li>
<li><a href="/wiki/Template:Congenital_malformations_and_deformations_of_nervous_system" title="Template:Congenital malformations and deformations of nervous system">Congenital</a></li>
<li><a href="/wiki/Template:Neurotrauma" title="Template:Neurotrauma">Injury</a></li>
<li><a href="/wiki/Template:Nervous_system_tumors" title="Template:Nervous system tumors">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:PNS_diseases_of_the_nervous_system" title="Template:PNS diseases of the nervous system">Other</a></li>
<li><a href="/wiki/Template:Nervous_and_musculoskeletal_system_symptoms_and_signs" title="Template:Nervous and musculoskeletal system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_nervous_system" title="Template:Eponymous medical signs for nervous system">eponymous</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Neuro_procedures" title="Template:Neuro procedures">Procedures</a></li>
<li><a href="/wiki/Template:Local_anesthetics" title="Template:Local anesthetics">Local anesthetics</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Endocrine_gland_neoplasia" title="Template:Endocrine gland neoplasia"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Endocrine_gland_neoplasia" title="Template talk:Endocrine gland neoplasia"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Endocrine_gland_neoplasia&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Neoplasm" title="Neoplasm">Tumors</a>: <a href="/wiki/Endocrine_gland_neoplasm" title="Endocrine gland neoplasm">endocrine gland neoplasia</a> (<a href="/wiki/ICD-10_Chapter_II:_Neoplasms#.28C73.E2.80.93C75.29_Malignant_neoplasms.2C_endocrine_glands_and_related_structures" title="ICD-10 Chapter II: Neoplasms">C73–C75/D34–D35</a>, <a href="/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_other_and_unspecified_sites_.28190.E2.80.93199.29" title="List of ICD-9 codes 140–239: neoplasms">193–194/226–227</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Pancreas" title="Pancreas">Pancreas</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Pancreatic_cancer" title="Pancreatic cancer">Pancreatic cancer</a></li>
<li><a href="/wiki/Pancreatic_neuroendocrine_tumor" title="Pancreatic neuroendocrine tumor">Pancreatic neuroendocrine tumor</a></li>
<li><a href="/wiki/Alpha_cell" title="Alpha cell">α</a>: <a href="/wiki/Glucagonoma" title="Glucagonoma">Glucagonoma</a></li>
<li><a href="/wiki/Beta_cell" title="Beta cell">β</a>: <a href="/wiki/Insulinoma" title="Insulinoma">Insulinoma</a></li>
<li><a href="/wiki/Delta_cell" title="Delta cell">δ</a>: <a href="/wiki/Somatostatinoma" title="Somatostatinoma">Somatostatinoma</a></li>
<li><a href="/wiki/G_cell" title="G cell">G</a>: <a href="/wiki/Gastrinoma" title="Gastrinoma">Gastrinoma</a></li>
<li><a href="/wiki/VIPoma" title="VIPoma">VIPoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Pituitary_neoplasm" title="Pituitary neoplasm" class="mw-redirect">Pituitary</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Pituitary_adenoma" title="Pituitary adenoma">Pituitary adenoma</a>: <a href="/wiki/Prolactinoma" title="Prolactinoma">Prolactinoma</a></li>
<li><a href="/wiki/Cushing%27s_disease" title="Cushing's disease">ACTH-secreting pituitary adenoma</a></li>
<li><a href="/wiki/Growth_hormone-secreting_pituitary_adenoma" title="Growth hormone-secreting pituitary adenoma" class="mw-redirect">GH-secreting pituitary adenoma</a></li>
<li><a href="/wiki/Craniopharyngioma" title="Craniopharyngioma">Craniopharyngioma</a></li>
<li><a href="/wiki/Pituicytoma" title="Pituicytoma">Pituicytoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Thyroid_neoplasm" title="Thyroid neoplasm">Thyroid</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Thyroid_cancer" title="Thyroid cancer">Thyroid cancer</a> (malignant): <i><a href="/wiki/Thyroid_epithelial_cell" title="Thyroid epithelial cell" class="mw-redirect">epithelial-cell</a></i> <i>carcinoma</i>
<ul>
<li><a href="/wiki/Papillary_thyroid_cancer" title="Papillary thyroid cancer">Papillary</a></li>
<li><a href="/wiki/Follicular_thyroid_cancer" title="Follicular thyroid cancer">Follicular</a>/<a href="/wiki/Hurthle_cell" title="Hurthle cell">Hurthle cell</a></li>
</ul>
</li>
<li><a href="/wiki/Parafollicular_cell" title="Parafollicular cell">Parafollicular cell</a>
<ul>
<li><a href="/wiki/Medullary_thyroid_cancer" title="Medullary thyroid cancer">Medullary</a></li>
</ul>
</li>
<li><a href="/wiki/Anaplastic_thyroid_cancer" title="Anaplastic thyroid cancer">Anaplastic</a></li>
<li><a href="/wiki/Thyroid_lymphoma" title="Thyroid lymphoma">Lymphoma</a></li>
<li><a href="/wiki/Squamous-cell_thyroid_carcinoma" title="Squamous-cell thyroid carcinoma">Squamous-cell carcinoma</a></li>
<li>Benign
<ul>
<li><a href="/wiki/Thyroid_adenoma" title="Thyroid adenoma">Thyroid adenoma</a></li>
<li><a href="/wiki/Struma_ovarii" title="Struma ovarii">Struma ovarii</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Adrenal_tumor" title="Adrenal tumor">Adrenal tumor</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Adrenal_cortex" title="Adrenal cortex">Cortex</a>
<ul>
<li><a href="/wiki/Adrenocortical_adenoma" title="Adrenocortical adenoma">Adrenocortical adenoma</a></li>
<li><a href="/wiki/Adrenocortical_carcinoma" title="Adrenocortical carcinoma">Adrenocortical carcinoma</a></li>
</ul>
</li>
<li><a href="/wiki/Adrenal_medulla" title="Adrenal medulla">Medulla</a>
<ul>
<li><a href="/wiki/Pheochromocytoma" title="Pheochromocytoma">Pheochromocytoma</a></li>
<li><strong class="selflink">Neuroblastoma</strong></li>
</ul>
</li>
<li><a href="/wiki/Paraganglioma" title="Paraganglioma">Paraganglioma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Parathyroid_gland" title="Parathyroid gland">Parathyroid</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Parathyroid_neoplasm" title="Parathyroid neoplasm">Parathyroid neoplasm</a></li>
<li><a href="/wiki/Parathyroid_adenoma" title="Parathyroid adenoma">Adenoma</a></li>
<li><a href="/wiki/Parathyroid_carcinoma" title="Parathyroid carcinoma">Carcinoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Pineal_gland" title="Pineal gland">Pineal gland</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Pinealoma" title="Pinealoma">Pinealoma</a></li>
<li><a href="/wiki/Pinealoblastoma" title="Pinealoblastoma">Pinealoblastoma</a></li>
<li><a href="/wiki/Pineocytoma" title="Pineocytoma">Pineocytoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Multiple_endocrine_neoplasia" title="Multiple endocrine neoplasia">MEN</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Multiple_endocrine_neoplasia_type_1" title="Multiple endocrine neoplasia type 1">1</a></li>
<li><a href="/wiki/Multiple_endocrine_neoplasia_type_2" title="Multiple endocrine neoplasia type 2">2A</a></li>
<li><a href="/wiki/Multiple_endocrine_neoplasia_type_2b" title="Multiple endocrine neoplasia type 2b">2B</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Endocrine_navs" title="Template:Endocrine navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Endocrine_navs" title="Template talk:Endocrine navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Endocrine_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Endocrine_system" title="Endocrine system">hormones</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Endocrine_system_anatomy" title="Template:Endocrine system anatomy">Glands</a></li>
<li><a href="/wiki/Template:Hormones" title="Template:Hormones">Hormones</a>
<ul>
<li>thyroid
<ul>
<li><i><a href="/wiki/Template:Thyroid_hormone_intermediates" title="Template:Thyroid hormone intermediates">intermediates</a></i></li>
<li><i><a href="/wiki/Template:Thyroid_hormone_metabolism_enzymes_and_transporters" title="Template:Thyroid hormone metabolism enzymes and transporters">metabolism</a></i></li>
</ul>
</li>
<li><a href="/wiki/Template:Mineralocorticoids" title="Template:Mineralocorticoids">mineralocorticoids</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Endocrinology_physiology" title="Template:Endocrinology physiology">Physiology</a></li>
<li><a href="/wiki/Template:Development_of_endocrine_system" title="Template:Development of endocrine system">Development</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Diabetes" title="Template:Diabetes">Diabetes</a></li>
<li><a href="/wiki/Template:Congenital_endocrine_disorders" title="Template:Congenital endocrine disorders">Congenital</a></li>
<li><a href="/wiki/Template:Endocrine_gland_neoplasia" title="Template:Endocrine gland neoplasia">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Endocrine_pathology" title="Template:Endocrine pathology">Other</a></li>
<li><a href="/wiki/Template:Symptoms_concerning_nutrition,_metabolism_and_development" title="Template:Symptoms concerning nutrition, metabolism and development">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_endocrinology,_nutrition,_and_metabolism" title="Template:Eponymous medical signs for endocrinology, nutrition, and metabolism">eponymous</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Endocrine_system_procedures" title="Template:Endocrine system procedures">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Calcium_homeostasis" title="Template:Calcium homeostasis">calcium balance</a></li>
<li><a href="/wiki/Template:Corticosteroids" title="Template:Corticosteroids">corticosteroids</a></li>
<li><a href="/wiki/Template:Oral_hypoglycemics_and_insulin_analogs" title="Template:Oral hypoglycemics and insulin analogs">oral hypoglycemics</a></li>
<li><a href="/wiki/Template:Pituitary_and_hypothalamic_hormones_and_analogues" title="Template:Pituitary and hypothalamic hormones and analogues" class="mw-redirect">pituitary and hypothalamic</a></li>
<li><a href="/wiki/Template:Thyroid_therapy" title="Template:Thyroid therapy">thyroid</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Arthritis_in_children" title="Template:Arthritis in children"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Arthritis_in_children" title="Template talk:Arthritis in children"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Arthritis_in_children&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Childhood_arthritis" title="Childhood arthritis">Arthritis in children</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Inflammation" title="Inflammation">Inflammatory</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">Idiopathic</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Juvenile_idiopathic_arthritis" title="Juvenile idiopathic arthritis">Juvenile idiopathic arthritis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Inflammatory disease</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Inflammatory_bowel_disease" title="Inflammatory bowel disease">Inflammatory bowel disease</a></li>
<li><a href="/wiki/Sarcoidosis" title="Sarcoidosis">Sarcoidosis</a></li>
<li><a href="/wiki/Cystic_fibrosis" title="Cystic fibrosis">Cystic fibrosis</a></li>
<li><a href="/wiki/Autoimmune_hepatitis" title="Autoimmune hepatitis">Autoimmune hepatitis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Tumors_of_the_hematopoietic_and_lymphoid_tissues" title="Tumors of the hematopoietic and lymphoid tissues">Hematological malignancy</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">Acute lymphoblastic leukemia</a></li>
<li><a href="/wiki/Lymphoma" title="Lymphoma">Lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cancer" title="Cancer">Malignancy</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><strong class="selflink">Neuroblastoma</strong></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>post-streptococcal</li>
<li><a href="/wiki/Rheumatic_fever" title="Rheumatic fever">Rheumatic fever</a></li>
<li>postenteric, post-viral</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Infection</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Septic_arthritis" title="Septic arthritis">Septic arthritis</a></li>
<li><a href="/wiki/Osteomyelitis" title="Osteomyelitis">Osteomyelitis</a></li>
<li><a href="/wiki/Tuberculosis" title="Tuberculosis">Tuberculosis</a></li>
<li><a href="/wiki/Lyme_disease#Late_disseminated_infection" title="Lyme disease">Lyme arthritis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Mechanical</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Osgood%E2%80%93Schlatter_disease" title="Osgood–Schlatter disease">Osgood–Schlatter disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Tumours of cartilage bone or muscle</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">Benign</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Osteoid_osteoma" title="Osteoid osteoma">Osteoid osteoma</a></li>
<li><a href="/wiki/Pigmented_villonodular_synovitis" title="Pigmented villonodular synovitis">Pigmented villonodular synovitis</a></li>
<li><a href="/wiki/Hemangioma" title="Hemangioma">Hemangioma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Malignant</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Synovial_sarcoma" title="Synovial sarcoma">Synovial sarcoma</a></li>
<li><a href="/wiki/Rhabdomyosarcoma" title="Rhabdomyosarcoma">Rhabdomyosarcoma</a></li>
<li><a href="/wiki/Ewing%27s_sarcoma" title="Ewing's sarcoma">Ewing's sarcoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Central Nervous System</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<dl>
<dd>Idiopathic pain syndromes</dd>
<dt>Local</dt>
<dd><a href="/wiki/Complex_regional_pain_syndrome" title="Complex regional pain syndrome">Complex regional pain syndrome</a>/Reflex sympathetic dystrophy</dd>
<dt>Generalized</dt>
<dd><a href="/wiki/Fibromyalgia" title="Fibromyalgia">Fibromyalgia</a></dd>
</dl>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Joint_navs" title="Template:Joint navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Joint_navs" title="Template talk:Joint navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Joint_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Joint" title="Joint">joint</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Joints" title="Template:Joints">Anatomy</a>
<ul>
<li><a href="/wiki/Template:Joints_of_head_and_neck" title="Template:Joints of head and neck">head and neck</a></li>
<li><a href="/wiki/Template:Cranial_fibrous_joints" title="Template:Cranial fibrous joints">cranial</a></li>
<li><a href="/wiki/Template:Joints_of_upper_limbs" title="Template:Joints of upper limbs">arms</a></li>
<li><a href="/wiki/Template:Joints_of_torso_and_pelvis" title="Template:Joints of torso and pelvis">torso and pelvis</a></li>
<li><a href="/wiki/Template:Joints_of_lower_limbs" title="Template:Joints of lower limbs">legs</a></li>
<li><a href="/wiki/Template:Bursae_and_sheaths" title="Template:Bursae and sheaths">bursae and sheathes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Bone_and_cartilage_physiology" title="Template:Bone and cartilage physiology">Physiology</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Arthropathies_and_related_conditions" title="Template:Arthropathies and related conditions">Arthritis</a>
<ul>
<li><a href="/wiki/Template:Acquired_musculoskeletal_deformities" title="Template:Acquired musculoskeletal deformities">acquired</a></li>
<li><a href="/wiki/Template:Spinal_disease" title="Template:Spinal disease">back</a></li>
<li><a href="/wiki/Template:Arthritis_in_children" title="Template:Arthritis in children">childhood</a></li>
<li><a href="/wiki/Template:Soft_tissue_disorders" title="Template:Soft tissue disorders">soft tissue</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Congenital_malformations_and_deformations_of_musculoskeletal_system" title="Template:Congenital malformations and deformations of musculoskeletal system">Congenital</a></li>
<li><a href="/wiki/Template:Dislocations,_sprains_and_strains" title="Template:Dislocations, sprains and strains">Injury</a></li>
<li><a href="/wiki/Template:Nervous_and_musculoskeletal_system_symptoms_and_signs" title="Template:Nervous and musculoskeletal system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_skeletal_system_and_joints" title="Template:Eponymous medical signs for skeletal system and joints">eponymous</a></li>
<li><a href="/wiki/Template:Orthopaedic_Eponyms" title="Template:Orthopaedic Eponyms">orthopaedic</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Orthopedic_examination" title="Template:Orthopedic examination">Examination</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Bone,_cartilage,_and_joint_procedures" title="Template:Bone, cartilage, and joint procedures">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antirheumatic_products" title="Template:Antirheumatic products">rheumatoid arthritis</a></li>
<li><a href="/wiki/Template:Antigout_preparations" title="Template:Antigout preparations">gout</a></li>
<li><a href="/wiki/Template:Topical_products_for_joint_and_muscular_pain" title="Template:Topical products for joint and muscular pain">topical analgesics</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1011
CPU time usage: 1.281 seconds
Real time usage: 1.418 seconds
Preprocessor visited node count: 5472/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 358506/2097152 bytes
Template argument size: 1818/2097152 bytes
Highest expansion depth: 12/40
Expensive parser function count: 1/500
Lua time usage: 0.508/10.000 seconds
Lua memory usage: 3.72 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00% 1120.748      1 - -total
 60.31%  675.935      1 - Template:Reflist
 21.87%  245.090     48 - Template:Cite_journal
 18.12%  203.061     14 - Template:Navbox
 15.33%  171.837     35 - Template:Cite_web
 11.23%  125.911      1 - Template:Infobox_disease
 10.19%  114.241      1 - Template:Infobox
  5.99%   67.122      1 - Template:Nervous_tissue_tumors
  4.98%   55.803      1 - Template:Good_article
  4.49%   50.312      1 - Template:Top_icon
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:1624266-0!*!0!!en!4!* and timestamp 20150711145141 and revision id 669877984
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Neuroblastoma&amp;oldid=669877984">https://en.wikipedia.org/w/index.php?title=Neuroblastoma&amp;oldid=669877984</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Endocrine_neoplasia" title="Category:Endocrine neoplasia">Endocrine neoplasia</a></li><li><a href="/wiki/Category:Small_blue_round_cell_tumor" title="Category:Small blue round cell tumor">Small blue round cell tumor</a></li><li><a href="/wiki/Category:Brain_tumor" title="Category:Brain tumor">Brain tumor</a></li><li><a href="/wiki/Category:Dermal_and_subcutaneous_growths" title="Category:Dermal and subcutaneous growths">Dermal and subcutaneous growths</a></li><li><a href="/wiki/Category:Rare_cancers" title="Category:Rare cancers">Rare cancers</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:All_articles_with_dead_external_links" title="Category:All articles with dead external links">All articles with dead external links</a></li><li><a href="/wiki/Category:Articles_with_dead_external_links_from_April_2012" title="Category:Articles with dead external links from April 2012">Articles with dead external links from April 2012</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_with_DMOZ_links" title="Category:Articles with DMOZ links">Articles with DMOZ links</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li><li><a href="/wiki/Category:Good_articles" title="Category:Good articles">Good articles</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Neuroblastoma&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Neuroblastoma" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Neuroblastoma"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Neuroblastoma"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Neuroblastoma" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Neuroblastoma&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Neuroblastoma&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Neuroblastoma" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Neuroblastoma" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Neuroblastoma&amp;oldid=669877984" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Neuroblastoma&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q938205" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Neuroblastoma&amp;id=669877984" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Neuroblastoma">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Neuroblastoma&amp;oldid=669877984&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Neuroblastoma&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D9%88%D8%B1%D9%85_%D8%A7%D9%84%D8%AE%D9%84%D8%A7%D9%8A%D8%A7_%D8%A7%D9%84%D8%A8%D8%AF%D8%A7%D8%A6%D9%8A%D8%A9_%D8%A7%D9%84%D8%B9%D8%B5%D8%A8%D9%8A%D8%A9" title="ورم الخلايا البدائية العصبية – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-bg"><a href="//bg.wikipedia.org/wiki/%D0%9D%D0%B5%D0%B2%D1%80%D0%BE%D0%B1%D0%BB%D0%B0%D1%81%D1%82%D0%BE%D0%BC" title="Невробластом – Bulgarian" lang="bg" hreflang="bg">Български</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Neuroblastom" title="Neuroblastom – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Neuroblastoma" title="Neuroblastoma – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%86%D9%88%D8%B1%D9%88%D8%A8%D9%84%D8%A7%D8%B3%D8%AA%D9%88%D9%85%D8%A7" title="نوروبلاستوما – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Neuroblastome" title="Neuroblastome – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-hr"><a href="//hr.wikipedia.org/wiki/Neuroblastom" title="Neuroblastom – Croatian" lang="hr" hreflang="hr">Hrvatski</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Neuroblastoma" title="Neuroblastoma – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%A0%D7%95%D7%99%D7%A8%D7%95%D7%91%D7%9C%D7%A1%D7%98%D7%95%D7%9E%D7%94" title="נוירובלסטומה – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-kk"><a href="//kk.wikipedia.org/wiki/%D0%9D%D0%B5%D0%B9%D1%80%D0%BE%D0%B1%D0%BB%D0%B0%D1%81%D1%82%D0%BE%D0%BC%D0%B0" title="Нейробластома – Kazakh" lang="kk" hreflang="kk">Қазақша</a></li><li class="interlanguage-link interwiki-ml"><a href="//ml.wikipedia.org/wiki/%E0%B4%A8%E0%B5%8D%E0%B4%AF%E0%B5%82%E0%B4%B1%E0%B5%8B%E0%B4%AC%E0%B5%8D%E0%B4%B2%E0%B4%BE%E0%B4%B8%E0%B5%8D%E0%B4%B1%E0%B5%8D%E0%B4%B1%E0%B5%8B%E0%B4%AE" title="ന്യൂറോബ്ലാസ്റ്റോമ – Malayalam" lang="ml" hreflang="ml">മലയാളം</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Neuroblastoom" title="Neuroblastoom – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E7%A5%9E%E7%B5%8C%E8%8A%BD%E7%B4%B0%E8%83%9E%E8%85%AB" title="神経芽細胞腫 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-pl badge-Q17437796 badge-featuredarticle" title="featured article"><a href="//pl.wikipedia.org/wiki/Nerwiak_zarodkowy" title="Nerwiak zarodkowy – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Neuroblastoma" title="Neuroblastoma – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%9D%D0%B5%D0%B9%D1%80%D0%BE%D0%B1%D0%BB%D0%B0%D1%81%D1%82%D0%BE%D0%BC%D0%B0" title="Нейробластома – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Neuroblastoma" title="Neuroblastoma – Simple English" lang="simple" hreflang="simple">Simple English</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Neuroblastooma" title="Neuroblastooma – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Neuroblastom" title="Neuroblastom – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-tr"><a href="//tr.wikipedia.org/wiki/N%C3%B6roblastom" title="Nöroblastom – Turkish" lang="tr" hreflang="tr">Türkçe</a></li><li class="interlanguage-link interwiki-ur"><a href="//ur.wikipedia.org/wiki/%D8%B9%D8%B5%D8%A8%DB%8C_%D9%88%D8%B1%D9%85%D9%90_%D8%A7%D8%B1%D9%88%D9%85%DB%81" title="عصبی ورمِ ارومہ – Urdu" lang="ur" hreflang="ur">اردو</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q938205#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 4 July 2015, at 05:31.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Neuroblastoma&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":121,"wgHostname":"mw1074"});
}</script>
	</body>
</html>
